<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">ACS Omega</journal-id>
    <journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id>
    <journal-id journal-id-type="publisher-id">ao</journal-id>
    <journal-id journal-id-type="coden">acsodf</journal-id>
    <journal-title-group>
      <journal-title>ACS Omega</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2470-1343</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9476499</article-id>
    <article-id pub-id-type="doi">10.1021/acsomega.2c04305</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>SCMRSA: a New Approach
for Identifying and Analyzing
Anti-MRSA Peptides Using Estimated Propensity Scores of Dipeptides</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Charoenkwan</surname>
          <given-names>Phasit</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <name>
          <surname>Kanthawong</surname>
          <given-names>Sakawrat</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <name>
          <surname>Schaduangrat</surname>
          <given-names>Nalini</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <name>
          <surname>Li’</surname>
          <given-names>Pietro</given-names>
        </name>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <name>
          <surname>Moni</surname>
          <given-names>Mohammad Ali</given-names>
        </name>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath6">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3394-8709</contrib-id>
        <name>
          <surname>Shoombuatong</surname>
          <given-names>Watshara</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Modern
Management and Information Technology, College of Arts, Media and
Technology, <institution>Chiang Mai University</institution>, Chiang Mai 50200, <country>Thailand</country></aff>
      <aff id="aff2"><label>‡</label>Department
of Microbiology, Faculty of Medicine, <institution>Khon
Kaen University</institution>, Khon Kaen 40002, <country>Thailand</country></aff>
      <aff id="aff3"><label>§</label>Center
of Data Mining and Biomedical Informatics, Faculty of Medical Technology, <institution>Mahidol University</institution>, Bangkok 10700, <country>Thailand</country></aff>
      <aff id="aff4"><label>∥</label>Department
of Computer Science and Technology, <institution>University
of Cambridge</institution>, Cambridge CB3 0FD, <country>U.K.</country></aff>
      <aff id="aff5"><label>⊥</label>Artificial
Intelligence &amp; Digital Health, School of Health and Rehabilitation
Sciences, Faculty of Health and Behavioural Sciences, <institution>The University of Queensland</institution> St Lucia, Queensland 4072, <country>Australia</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>watshara.sho@mahidol.ac.th</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>01</day>
      <month>09</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>13</day>
      <month>09</month>
      <year>2022</year>
    </pub-date>
    <volume>7</volume>
    <issue>36</issue>
    <fpage>32653</fpage>
    <lpage>32664</lpage>
    <history>
      <date date-type="received">
        <day>08</day>
        <month>07</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>08</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2022 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2022</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_0008" id="ab-tgr1"/>
      </p>
      <p><italic>Staphylococcus aureus</italic> is
deemed
to be one of the major causes of hospital and community-acquired infections,
especially in methicillin-resistant <italic>S. aureus</italic> (MRSA) strains. Because antimicrobial peptides have captured attention
as novel drug candidates due to their rapid and broad-spectrum antimicrobial
activity, anti-MRSA peptides have emerged as potential therapeutics
for the treatment of bacterial infections. Although experimental approaches
can precisely identify anti-MRSA peptides, they are usually cost-ineffective
and labor-intensive. Therefore, computational approaches that are
able to identify and characterize anti-MRSA peptides by using sequence
information are highly desirable. In this study, we present the first
computational approach (termed SCMRSA) for identifying and characterizing
anti-MRSA peptides by using sequence information without the use of
3D structural information. In SCMRSA, we employed an interpretable
scoring card method (SCM) coupled with the estimated propensity scores
of 400 dipeptides. Comparative experiments indicated that SCMRSA was
more effective and could outperform several machine learning-based
classifiers with an accuracy of 0.960 and Matthews correlation coefficient
of 0.848 on the independent test data set. In addition, we employed
the SCMRSA-derived propensity scores to provide a more in-depth explanation
regarding the functional mechanisms of anti-MRSA peptides. Finally,
in order to serve community-wide use of the proposed SCMRSA, we established
a user-friendly webserver which can be accessed online at http://pmlabstack.pythonanywhere.com/SCMRSA.
SCMRSA is anticipated to be an open-source and useful tool for screening
and identifying novel anti-MRSA peptides for follow-up experimental
studies.</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Chiang Mai University</institution>
            <institution-id institution-id-type="doi">10.13039/501100002842</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NA</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>College of Arts, Media and Technology, Chiang Mai University</institution>
            <institution-id institution-id-type="doi">NA</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NA</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Mahidol University</institution>
            <institution-id institution-id-type="doi">10.13039/501100004156</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NA</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ao2c04305</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ao2c04305</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p><italic>Staphylococcus aureus</italic> is a Gram-positive
pathogen forming grape-like clusters of cocci that can also be found
on multiple parts of healthy people, such as the skin and nose.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> It causes a variety of infections, from skin
infections, abscesses, impetigo, cellulitis, and folliculitis to life-threatening
diseases, such as pneumonia, endocarditis, toxic shock syndrome, and
sepsis.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Moreover, <italic>S. aureus</italic> is considered to be one of the major causes of hospital and community-acquired
infections, especially methicillin-resistant <italic>S. aureus</italic> (MRSA) strains.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> MRSA was initially isolated
from patients hospitalized in the 1960s and rapidly became an important
problem in the community and healthcare system.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> The data from the National Antimicrobial Resistance Surveillance
center (NARST) of Thailand showed that, MRSA had been found in around
50% of the total <italic>S. aureus</italic> isolates
from clinical specimens in some tertiary hospitals of Thailand.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> In addition, MRSA accounted for 59.5% of nosocomial <italic>S. aureus</italic> infections in intensive care units (ICUs)
in the United States.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> Even with the current
development of new antimicrobial agents, MRSA remains a difficult-to-treat
superbug with persistently high mortality. Therefore, MRSA has emerged
as one of the greatest challenges for healthcare professionals globally.</p>
    <p>Due to the ongoing resistance toward conventional antibiotics of
various pathogens, antimicrobial peptides (AMPs) have captured attention
as novel drug candidates with rapidly and broad-spectrum antimicrobial
activity, including antibiotic-resistant microorganisms, such as MRSA.
In general, AMPs are small cationic and amphipathic molecules<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> ranging between 12 and 50 amino acids in length.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Owing to their intrinsic physicochemical properties,
such as amino acid sequence, charge, amphipathic property, and secondary
structure, AMPs adopts various mechanisms to kill bacteria.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Disrupting the integrity of the cell membrane
has been reported to be the main mechanism of action of AMPs. However,
the broad-spectrum activity of AMPs may result in the coincidental
selection and proliferation of resistant bacterial strains, creating
pathogens from previously harmless organisms and increasing the possibility
of an ecological imbalance in the microbiota.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> Therefore, species-specific peptides are of tremendous value. Furthermore,
peptides with potent activity against MRSA have been discovered either
naturally or designed synthetically.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Nevertheless,
the conventional methods for effectively screening and designing novel
AMPs, such as antimicrobial susceptibility testing (AST), are time-consuming
and expensive. Therefore, sequence-based computational tools that
can rapidly and accurately identify potential anti-MRSA peptides based
on sequence information could serve a great purpose in their large-scale
identification.</p>
    <p>Until now, there is no computational approach
in existence that
has been proposed for identifying anti-MRSA peptides by using sequence
information without the use of 3D structural information. With such
potential of anti-MRSA peptides for the treatment of bacterial infections,
in this study, we develop SCMRSA, a sequence-based computational approach
for identifying and analyzing anti-MRSA peptides. In brief, the construction
and development of SCMRSA involves the following steps (as summarized
in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>): (i) we
established a benchmark data set by collecting positive samples from
the AMP database version 3 (ADP3)<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> and
negative samples from the article of Pang et al.;<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> (ii) we employed an interpretable scoring card method (SCM)
to develop the prediction model (SCMRSA); and (iii) SCMRSA-derived
propensities of 20 amino acids and 400 dipeptides were generated and
optimized using the genetic algorithm (GA) based on the 10-fold cross-validation
scheme. The predictive performance on the independent test data set
show that SCMRSA can outperform several machine learning (ML)-based
classifiers, including decision tree (DT), k-nearest neighbor (KNN),
logistic regression (LR), naive Bayes (NB), and partial least squares
regression (PLS) classifiers, as judged by predictive ability, cost-effectiveness,
and interpretability. In addition, the SCMRSA-derived propensity scores
were employed to provide insights into the functional mechanisms of
anti-MRSA peptides. Finally, in order to serve a community-wide use
of the proposed SCMRSA, we implemented an online webserver, which
is available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pmlabstack.pythonanywhere.com/SCMRSA">http://pmlabstack.pythonanywhere.com/SCMRSA</uri>.</p>
    <fig id="fig1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Schematic framework of
the development of SCMRSA. The schematic
framework of the development of SCMRSA contains four main steps: (i)
training and independent data set preparation, (ii) SCMRSA-based propensity
score generation and optimization, (iii) anti-MRSA peptide identification
and characterization, and (iv) SCMRSA webserver construction.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_0002" id="gr1" position="float"/>
    </fig>
  </sec>
  <sec id="sec2">
    <label>2</label>
    <title>Materials and Methods</title>
    <sec id="sec2.1">
      <label>2.1</label>
      <title>Data Collection and Curation</title>
      <p>In this
study, we established a new data set, including 183 experimentally
validated anti-MRSA peptides (positive samples) from ADP3.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> For the negative samples, we employed 4979 peptides
without anti-MRSA activity (called non-anti-MRSA peptides) from an
article of Pang et al.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> Next, a CD-HIT
[40] threshold of 0.8 was applied to remove sequence redundancy in
both the anti-MRSA and non-anti-MRSA samples and to avoid overestimation
of the predictive performance. As a result, we obtained the final
non-redundant data set containing 148 positive and 847 negative samples.
After obtaining the non-redundant data sets, we used 80% of the samples
(118 positives and 678 negatives) as the training data set. As a result,
the independent test data set contained 30 positives and 169 negatives.</p>
    </sec>
    <sec id="sec2.2">
      <label>2.2</label>
      <title>Overview Framework of SCMRSA</title>
      <p>Previously,
Huang et al.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> and Charoenkwan et al.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> introduced a simple and interpretable SCM method. To date, this
method has successfully overcome the limitations of existing computational
black-box approaches, such as SVM<sup><xref ref-type="bibr" rid="ref16">16</xref>−<xref ref-type="bibr" rid="ref18">18</xref></sup> and deep learning (DL)<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> approaches, by generating the propensity scores
of amino acids and dipeptides in order to provide information about
the global property of general proteins and peptides. Herein, we utilized
the SCM method<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> to build an interpretable
model for predicting and characterizing anti-MRSA peptides. The design
and development of SCMRSA based on the SCM method are summarized in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>, including initial
(initial-DPS) and optimal (DPS) propensity score generation, a scoring
function construction, prediction of an uncharacterized peptide, and
performance evaluation.</p>
      <p>Phase 1: generating a matrix initial-DPS,
as follows:</p>
      <p>Step 1: calculating the numbers of 400 dipeptides
(<italic>i</italic> = 1,2,3, ..., 20) in positive and negative classes
to construct
matrices (<italic>P</italic><sub><italic>ij</italic></sub> = (<italic>n</italic><sub><italic>ij</italic></sub>|<italic>C</italic> = 1))
and (<italic>N</italic><sub><italic>ij</italic></sub> = (<italic>n</italic><sub><italic>ij</italic></sub>|<italic>C</italic> = 0)), respectively,
where 1 and 0 denote positive and negative classes, respectively.</p>
      <p>Step 2: computing compositions of <italic>nP</italic><sub><italic>i</italic></sub> and <italic>nN</italic><sub><italic>i</italic></sub> by dividing them with the number of occurrences of dipeptides in
each class, as follows<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_m001" position="anchor"/><label>1</label></disp-formula><disp-formula id="eq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_m002" position="anchor"/><label>2</label></disp-formula>where <italic>L</italic><sub>p</sub> and <italic>L</italic><sub>n</sub> denote total numbers of dipeptides in positive
and negative classes, respectively.</p>
      <p>Step 3: computing the score
of the <italic>i</italic>th dipeptide
by subtracting <italic>nP</italic><sub><italic>i</italic></sub> from <italic>nN</italic><sub><italic>i</italic></sub>.<disp-formula id="eq3"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_m003" position="anchor"/><label>3</label></disp-formula></p>
      <p>Step 4: the scores of init-DPS<sub><italic>ij</italic></sub> are
normalized into the range of 0–1000 for the convenience of
the prediction and characterization of anti-MRSA peptides.</p>
      <p>Phase
2: optimizing initial-DPS by using the GA algorithm in order
to enhance the discriminative ability and conserve the information
of anti-MRSA peptides. The fitness function used in this study is
represented by<disp-formula id="eq4"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_m004" position="anchor"/><label>4</label></disp-formula></p>
      <p>As can be seen, this fitness function
includes AUC and <italic>R</italic>, which represent area under the
receiver operating characteristics
(ROC) curve (AUC) and Pearson’s correlation coefficient (<italic>R</italic> value) between initial-DPS and DPS, respectively. The
10-fold cross-validation scheme was performed to control overfitting
and biasness.</p>
      <p>Phase 3: building a scoring-based predictor <italic>S</italic>(<italic>P</italic>). The <italic>S</italic>(<italic>P</italic>) is defined
as follows<disp-formula id="eq5"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_m005" position="anchor"/><label>5</label></disp-formula>where <italic>S</italic><sub><italic>i</italic></sub> and DPS<sub><italic>i</italic></sub> define the occurrence
number and the <italic>i</italic>th dipeptide propensity score.</p>
      <p>Phase 4: discriminating uncharacterized peptide <italic>P</italic>. In the meantime, the optimal threshold value was determined by
maximizing the performance in terms of accuracy (ACC) based on the
training data set. Particularly, <italic>P</italic> is predicted as
the positive class if the score from <italic>S</italic>(<italic>P</italic>) is &gt; threshold value, otherwise <italic>P</italic> is predicted
as the negative class. The propensity scores of the 20 amino acids
can be generated in the same procedure. Herein, the optimized propensity
scores of amino acids and dipeptides are denoted as APS and DPS, respectively,
for the convenience of discussion. More detailed information for the
SCM classifier construction is provided in our previous studies.<sup><xref ref-type="bibr" rid="ref13">13</xref>−<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref20">20</xref></sup></p>
    </sec>
    <sec id="sec2.3">
      <label>2.3</label>
      <title>Identification of Informative Physicochemical
Properties</title>
      <p>In this study, the SCM approach coupled with 20
amino acid propensities (or APS) were utilized for determining informative
physicochemical properties (PCPs) from the amino acid index database
(AAindex) so as to analyze and characterize anti-MRSA peptides. The
process of identifying informative PCP approach contained multiple
main steps, as follows. First, we excluded all PCPs having not applicable
(NA) and then obtained 531 PCPs in this study. Each PCP is defined
by a set of 20 numerical values for 20 amino acids. Second, we calculated
the R value between each of the 531 PCPs and APS. Please note that
PCPs affording the largest R values are deemed to be the most important
properties in anti-MRSA peptides. Third, the 20 top-ranked PCPs with
the largest R values were reported and used for further analysis.</p>
    </sec>
    <sec id="sec2.4">
      <label>2.4</label>
      <title>ML-Based and Blast-Based Classifiers</title>
      <p>Here, we compared the performance of SCMRSA with several ML-based
and Blast-based classifiers. Specifically, we employed seven popular
ML algorithms [i.e., DT, KNN, LR, NB, PLS, and SVM with linear kernel
and radial basis function kernel (referred herein as SVMLN and SVMRBF,
respectively)] and five conventional feature descriptors<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> [i.e., AAC, AAI, DPC, PCP, and composition–transition–distribution
(CTD)] to generate a total of 35 ML classifiers. All the ML classifiers
were created using Scikit-learn v0.22.0 package<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04305/suppl_file/ao2c04305_si_001.pdf">Supporting Information</ext-link>, Table
S1). For the BLAST-based classifier, the training data set was considered
as the BLASTP database, while the independent data set was employed
as the BLASTP query sequences. Detailed information for the construction
of ML-based<sup><xref ref-type="bibr" rid="ref23">23</xref>−<xref ref-type="bibr" rid="ref26">26</xref></sup> and Blast-based<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref27">27</xref></sup> classifiers are available in
our previous studies.</p>
    </sec>
    <sec id="sec2.5">
      <label>2.5</label>
      <title>Performance Evaluation</title>
      <p>We employed
six common performance measures to examine the predictive ability
and effectiveness of the proposed model, including ACC, AUC, sensitivity
(Sn), specificity (Sp), balanced accuracy (BACC), and Matthew’s
correlation coefficient (MCC).<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref></sup> These performance measures
are described by the following equations<disp-formula id="eq6"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_m006" position="anchor"/><label>6</label></disp-formula><disp-formula id="eq7"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_m007" position="anchor"/><label>7</label></disp-formula><disp-formula id="eq8"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_m008" position="anchor"/><label>8</label></disp-formula><disp-formula id="eq9"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_m009" position="anchor"/><label>9</label></disp-formula><disp-formula id="eq10"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_m010" position="anchor"/><label>10</label></disp-formula>where TP and TN indicate the number of true
positives and true negatives, respectively, while FP and FN represent
the number of false positives and false negatives, respectively.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref30">30</xref>−<xref ref-type="bibr" rid="ref32">32</xref></sup></p>
    </sec>
  </sec>
  <sec id="sec3">
    <label>3</label>
    <title>Results and Discussion</title>
    <sec id="sec3.1">
      <label>3.1</label>
      <title>Performance Evaluation of Different Sets of
Propensity Scores</title>
      <p>In this section, we evaluated the impact
of different sets of APS and DPS in anti-MRSA peptide identification.
As mentioned in the Overview Framework of SCMRSA section, the GA algorithm
was employed for optimization of APS and DPS based on the training
data set. Because of the characteristics of the GA algorithm, we generated
10 different sets for each type of propensity scores (10 APS and 10
DPS). Each set of propensity scores was used to individually build
the SCM classifier and its performance was evaluated using the 10-fold
cross-validation tests. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04305/suppl_file/ao2c04305_si_001.pdf">Supporting Information</ext-link>, tables S2 and S3 show the 10-fold cross-validation results of the
different SCM classifiers trained using different sets of APS and
DPS.</p>
      <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04305/suppl_file/ao2c04305_si_001.pdf">Supporting Information</ext-link>, Table
S2 shows that the APS from the 4th experiment achieves the highest
MCC of 0.797 with BACC of 0.883 and AUC of 0.940. On the other hand,
the second best and third best sets of APS were obtained from the
first (MCC of 0.791) and ninth (MCC of 0.790) experiments. In the
case of DPS, the sixth experiment provided the highest MCC of 0.880
with a BACC of 0.927 and AUC of 0.969, while the DPS from the third
and seventh experiments yielded the second and third highest MCC of
0.871 and 0.865, respectively (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04305/suppl_file/ao2c04305_si_001.pdf">Supporting Information</ext-link>, Table S3). As a result, the APS from the fourth experiment and
the DPS from the sixth experiment were regarded as the optimal sets
of APS and DPS for identifying anti-MRSA peptides, respectively (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). From <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, we notice that the optimal
set of DPS exhibits the best of all five performance metrics. Remarkably,
BACC, Sn, and MCC of the optimal set of DPS were 4.4, 7.7, and 8.3%
higher than the optimal set of APS, respectively. For the performance
on the independent test data set (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04305/suppl_file/ao2c04305_si_001.pdf">Supporting Information</ext-link>, Tables S4 and S5), the optimal set of DPS still performed higher
than the optimal set of APS in terms BACC, Sn, MCC, and AUC. Thus,
our comparative results confirmed that the optimal set of DPS could
effectively be used for identifying anti-MRSA peptides. In addition,
the propensities of 400 dipeptides are provided in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>.</p>
      <fig id="fig2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Propensity scores of
400 dipeptides to be anti-MRSA peptides obtained
from the proposed SCMRSA.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_0003" id="gr2" position="float"/>
      </fig>
      <table-wrap id="tbl1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Performance Comparison for the Optimal
Sets of APS and DPS</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">cross-validation</th>
              <th style="border:none;" align="center">feature</th>
              <th style="border:none;" align="center" char=".">ACC</th>
              <th style="border:none;" align="center" char=".">BACC</th>
              <th style="border:none;" align="center" char=".">Sn</th>
              <th style="border:none;" align="center" char=".">Sp</th>
              <th style="border:none;" align="center" char=".">MCC</th>
              <th style="border:none;" align="center" char=".">AUC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">10-fold CV</td>
              <td style="border:none;" align="left">APS</td>
              <td style="border:none;" align="char" char=".">0.950</td>
              <td style="border:none;" align="char" char=".">0.883</td>
              <td style="border:none;" align="char" char=".">0.788</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.797</td>
              <td style="border:none;" align="char" char=".">0.940</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="char" char=".">0.970</td>
              <td style="border:none;" align="char" char=".">0.927</td>
              <td style="border:none;" align="char" char=".">0.865</td>
              <td style="border:none;" align="char" char=".">0.988</td>
              <td style="border:none;" align="char" char=".">0.880</td>
              <td style="border:none;" align="char" char=".">0.969</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">independent test</td>
              <td style="border:none;" align="left">APS</td>
              <td style="border:none;" align="char" char=".">0.960</td>
              <td style="border:none;" align="char" char=".">0.894</td>
              <td style="border:none;" align="char" char=".">0.800</td>
              <td style="border:none;" align="char" char=".">0.988</td>
              <td style="border:none;" align="char" char=".">0.837</td>
              <td style="border:none;" align="char" char=".">0.940</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="char" char=".">0.960</td>
              <td style="border:none;" align="char" char=".">0.935</td>
              <td style="border:none;" align="char" char=".">0.900</td>
              <td style="border:none;" align="char" char=".">0.970</td>
              <td style="border:none;" align="char" char=".">0.848</td>
              <td style="border:none;" align="char" char=".">0.986</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>As mentioned in the Scoring card method section, the
improved performance
of the SCM classifier is mainly due to the optimal set of DPS (called
DPS for short), derived from the GA algorithm. Thus, to explain this
evidence, the performance of DPS was compared with initial-DPS. <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> lists the performance
of the DPS and initial-DPS on the training and independent test data
set. The results indicated that the DPS significantly outperformed
initial-DPS on both the training and independent data sets. To be
specific, the ACC, BACC, Sn, and MCC of the DPS were 2.51, 10.19,
4.56, and 9.16% higher than the initial-DPS, respectively, on the
independent test data set. In addition, <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref> shows that the initial-DPS (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A) has a large overlapped region
between the positives and negatives as compared to DPS (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B) as analyzed on the training
data set. Altogether, our analysis results confirmed that the estimated
propensities of 400 dipeptides (DPS) provide more discriminative power
for identifying anti-MRSA peptides than initial-DPS.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Histogram plot represents
the scores of positives (anti-MRSA peptides)
and negatives (non-anti-MRSA peptides) derived from SCMRSA by using
initial-DPS (A) and DPS (B) on the training data set, where the mean
and standard deviation are indicated by the bars and closed circles.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_0004" id="gr3" position="float"/>
      </fig>
      <table-wrap id="tbl2" position="float">
        <label>Table 2</label>
        <caption>
          <title>Performance Comparison of Initial-DPS
and DPS</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">cross-validation</th>
              <th style="border:none;" align="center">feature</th>
              <th style="border:none;" align="center" char=".">ACC</th>
              <th style="border:none;" align="center" char=".">BACC</th>
              <th style="border:none;" align="center" char=".">Sn</th>
              <th style="border:none;" align="center" char=".">Sp</th>
              <th style="border:none;" align="center" char=".">MCC</th>
              <th style="border:none;" align="center" char=".">AUC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">10-fold CV</td>
              <td style="border:none;" align="left">initial-DPS</td>
              <td style="border:none;" align="char" char=".">0.925</td>
              <td style="border:none;" align="char" char=".">0.720</td>
              <td style="border:none;" align="char" char=".">0.829</td>
              <td style="border:none;" align="char" char=".">0.960</td>
              <td style="border:none;" align="char" char=".">0.697</td>
              <td style="border:none;" align="char" char=".">0.957</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="char" char=".">0.970</td>
              <td style="border:none;" align="char" char=".">0.927</td>
              <td style="border:none;" align="char" char=".">0.865</td>
              <td style="border:none;" align="char" char=".">0.988</td>
              <td style="border:none;" align="char" char=".">0.880</td>
              <td style="border:none;" align="char" char=".">0.969</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">independent test</td>
              <td style="border:none;" align="left">initial-DPS</td>
              <td style="border:none;" align="char" char=".">0.935</td>
              <td style="border:none;" align="char" char=".">0.833</td>
              <td style="border:none;" align="char" char=".">0.854</td>
              <td style="border:none;" align="char" char=".">0.953</td>
              <td style="border:none;" align="char" char=".">0.756</td>
              <td style="border:none;" align="char" char=".">0.976</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="char" char=".">0.960</td>
              <td style="border:none;" align="char" char=".">0.935</td>
              <td style="border:none;" align="char" char=".">0.900</td>
              <td style="border:none;" align="char" char=".">0.970</td>
              <td style="border:none;" align="char" char=".">0.848</td>
              <td style="border:none;" align="char" char=".">0.986</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="sec3.2">
      <label>3.2</label>
      <title>Comparison of SCMRSA with BLAST-Based Predictor
and Conventional ML-Based Classifiers</title>
      <p>To the best of the
authors’ knowledge, SCMRSA is the first computational model
for identifying peptides with or without anti-MRSA activity. Thus,
we evaluated and compared the performance of SCMRSA against the BLAST-based
predictors and conventional ML-based classifiers trained with seven
ML algorithms and five sequence-based feature descriptors (as described
in the ML-Based and Blast-Based Classifiers section). <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04305/suppl_file/ao2c04305_si_001.pdf">Supporting Information</ext-link>, Tables S6–S8 show
the performance of the BLAST-based predictor and 35 ML classifiers.
In addition, we compared the performance of the proposed SCMRSA with
five best-performing ML classifiers having the highest cross-validation
BACC for convenience of discussion. <xref rid="fig4" ref-type="fig">Figures <xref rid="fig4" ref-type="fig">4</xref></xref> and <xref rid="fig5" ref-type="fig">5</xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04305/suppl_file/ao2c04305_si_001.pdf">Supporting Information</ext-link>, Table S9 present the
performance comparison of SCMRSA with the five best-performing ML
classifiers, including SVMRBF-AAI, SVMRBF-AAC, SVMRBF-CTD, SVMLN-AAI,
and LR-CTD.</p>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Performance evaluations of SCMRSA and conventional ML-based classifiers
based on 10-fold cross-validation test (A,B) and independent test
(C,D).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_0005" id="gr4" position="float"/>
      </fig>
      <fig id="fig5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Performance evaluations of SCMRSA and five best-performing
ML classifiers
as indicated by the 10-fold cross-validation test. Prediction results
of SCMRSA and five best-performing ML classifiers in terms of ACC,
BACC, Sn, Sp, and MCC (A). ROC curves and AUC values of SCMRSA and
five best-performing ML classifiers (B).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_0006" id="gr5" position="float"/>
      </fig>
      <p>We first compared the performance of SCMRSA with
the BLAST-based
predictor. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04305/suppl_file/ao2c04305_si_001.pdf">Supporting Information</ext-link>, Table
S8 shows that the BLAST-based predictor using an <italic>E</italic>-value cut off of 0.1 provides the highest BACC of 0.869 with an
ACC of 0.940 and MCC of 0.758. However, the MCC, BACC, and Sn of SCMRSA
were 8.93, 6.67, and 13.33%, respectively, higher than the BLAST-based
predictor. When compared with the five best-performing ML classifiers
on the training data set, SCMRSA still attained the best overall performance
in terms of ACC, BACC, Sn, and MCC (<xref rid="fig4" ref-type="fig">Figures <xref rid="fig4" ref-type="fig">4</xref></xref> and <xref rid="fig5" ref-type="fig">5</xref>). In the meantime,
SVMRBF-AAI yielded the second highest BACC of 0.899. As can be seen,
the BACC, Sn, and MCC of SCMRSA were 2.76, 5.08, and 4.66%, respectively,
higher than the second-best method SVMRBF-AAI. From <xref rid="fig4" ref-type="fig">Figures <xref rid="fig4" ref-type="fig">4</xref></xref> and <xref rid="fig5" ref-type="fig">5</xref>, the largest BACC of 0.947 is achieved by SVMRBF-AAC, while SVMRBF-AAI
and SCMRSA yield the second and third largest BACC of 0.941 and 0.935,
respectively.</p>
      <p>It is well-known that SVMRBF-AAC and SVMRBF-AAI
are defined as
computational black-box approaches because the SVM algorithm cannot
directly provide information of the relationship between each feature
and the model output. As such, we were motivated to utilize SCM methods
for developing a simple and highly interpretable model SCMRSA. The
contribution of SCMRSA can be summarized in the following three aspects:
(i) SCMRSA is able to discriminate between anti-MRSA and non-anti-MRSA
using only the simple weighted-sum function, highlighting that SCMRSA
will be a powerful tool for large-scale identification of anti-MRSA;
(ii) SCMRSA is able to create the propensities of amino acids and
dipeptides. These propensity scores could provide a good understanding
of functional mechanisms of anti-MRSA peptides and (iii) SCMRSA attained
a competitive performance as compared with SVM-based classifiers and
also outperformed several ML-based classifiers, including DT, KNN,
LR, NB, and PLS, in terms of cost-effectiveness and interpretability.</p>
    </sec>
    <sec id="sec3.3">
      <label>3.3</label>
      <title>Analysis of Potential Anti-MRSA Peptides on
the Training Data Set</title>
      <p>In this section, we utilized our proposed
approach SCMRSA to determine potential anti-MRSA peptides on the training
data set. Particularly, for a given peptide sequence <italic>P</italic>, SCMRSA will provide us its anti-MRSA score. Note that peptides
with the largest anti-MRSA score were assumed to be potential anti-MRSA
peptides. <xref rid="tbl3" ref-type="other">Tables <xref rid="tbl3" ref-type="other">3</xref></xref> and <xref rid="tbl4" ref-type="other">4</xref> list the top 20 potential anti-MRSA peptides having
the highest and lowest anti-MRSA scores, respectively, along with
their important PCPs, including hydrophobicity (PCP1), hydropathicity
(PCP2), charge (PCP3), and pI (PCP4).</p>
      <table-wrap id="tbl3" position="float">
        <label>Table 3</label>
        <caption>
          <title>Top 20 High-Potential Anti-MRSA Peptides
Having the Highest <italic>S</italic>(<italic>P</italic>) along with
Their Important Physicochemical Properties<xref rid="t3fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">#</th>
              <th style="border:none;" align="center">peptide sequence</th>
              <th style="border:none;" align="center" char=".">score</th>
              <th style="border:none;" align="center" char=".">PCP1</th>
              <th style="border:none;" align="center" char=".">PCP2</th>
              <th style="border:none;" align="center" char=".">PCP3</th>
              <th style="border:none;" align="center" char=".">PCP4</th>
              <th style="border:none;" align="center">references</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">FLKAIKKFGKEFKKIGAKLK</td>
              <td style="border:none;" align="char" char=".">598.26</td>
              <td style="border:none;" align="char" char=".">–0.2</td>
              <td style="border:none;" align="char" char=".">–0.33</td>
              <td style="border:none;" align="char" char=".">7</td>
              <td style="border:none;" align="char" char=".">10.48</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref33">33</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">2</td>
              <td style="border:none;" align="left">FLPAALAGIGGILGKLF</td>
              <td style="border:none;" align="char" char=".">560.63</td>
              <td style="border:none;" align="char" char=".">0.28</td>
              <td style="border:none;" align="char" char=".">1.56</td>
              <td style="border:none;" align="char" char=".">1</td>
              <td style="border:none;" align="char" char=".">9.11</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref34">34</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left">KRIGLIRLIGKILRGLRRLG</td>
              <td style="border:none;" align="char" char=".">558.37</td>
              <td style="border:none;" align="char" char=".">–0.23</td>
              <td style="border:none;" align="char" char=".">0.24</td>
              <td style="border:none;" align="char" char=".">7</td>
              <td style="border:none;" align="char" char=".">12.61</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref35">35</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left">FLPLIAGLFGKIF</td>
              <td style="border:none;" align="char" char=".">529.92</td>
              <td style="border:none;" align="char" char=".">0.31</td>
              <td style="border:none;" align="char" char=".">1.74</td>
              <td style="border:none;" align="char" char=".">1</td>
              <td style="border:none;" align="char" char=".">9.11</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref36">36</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">5</td>
              <td style="border:none;" align="left">FLSAITSILGKFF</td>
              <td style="border:none;" align="char" char=".">528.92</td>
              <td style="border:none;" align="char" char=".">0.21</td>
              <td style="border:none;" align="char" char=".">1.44</td>
              <td style="border:none;" align="char" char=".">1</td>
              <td style="border:none;" align="char" char=".">9.11</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref37">37</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">6</td>
              <td style="border:none;" align="left">FLSIIAKVLGSLF</td>
              <td style="border:none;" align="char" char=".">523.00</td>
              <td style="border:none;" align="char" char=".">0.26</td>
              <td style="border:none;" align="char" char=".">1.86</td>
              <td style="border:none;" align="char" char=".">1</td>
              <td style="border:none;" align="char" char=".">9.11</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref38">38</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">7</td>
              <td style="border:none;" align="left">KRFKKFFRKIKKGFRKIFKKTKIFIGGTIPI</td>
              <td style="border:none;" align="char" char=".">520.07</td>
              <td style="border:none;" align="char" char=".">–0.26</td>
              <td style="border:none;" align="char" char=".">–0.4</td>
              <td style="border:none;" align="char" char=".">13</td>
              <td style="border:none;" align="char" char=".">12.34</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref39">39</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">8</td>
              <td style="border:none;" align="left">GLSLLLSLGLKLL</td>
              <td style="border:none;" align="char" char=".">519.42</td>
              <td style="border:none;" align="char" char=".">0.21</td>
              <td style="border:none;" align="char" char=".">1.72</td>
              <td style="border:none;" align="char" char=".">1</td>
              <td style="border:none;" align="char" char=".">9.11</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">GWKKWLRKGAKHLGQAAIKGLAS</td>
              <td style="border:none;" align="char" char=".">514.27</td>
              <td style="border:none;" align="char" char=".">–0.16</td>
              <td style="border:none;" align="char" char=".">–0.49</td>
              <td style="border:none;" align="char" char=".">6.5</td>
              <td style="border:none;" align="char" char=".">11.39</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref40">40</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">10</td>
              <td style="border:none;" align="left">GFLGSLLKTGLKVGSNLL</td>
              <td style="border:none;" align="char" char=".">509.65</td>
              <td style="border:none;" align="char" char=".">0.08</td>
              <td style="border:none;" align="char" char=".">0.77</td>
              <td style="border:none;" align="char" char=".">2</td>
              <td style="border:none;" align="char" char=".">10.02</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref41">41</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">11</td>
              <td style="border:none;" align="left">FLPLLAGLAANFLPKIFCKITRK</td>
              <td style="border:none;" align="char" char=".">508.82</td>
              <td style="border:none;" align="char" char=".">0.04</td>
              <td style="border:none;" align="char" char=".">0.85</td>
              <td style="border:none;" align="char" char=".">4</td>
              <td style="border:none;" align="char" char=".">10.33</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref42">42</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">12</td>
              <td style="border:none;" align="left">GLLSLLSLLGKLL</td>
              <td style="border:none;" align="char" char=".">506.42</td>
              <td style="border:none;" align="char" char=".">0.21</td>
              <td style="border:none;" align="char" char=".">1.72</td>
              <td style="border:none;" align="char" char=".">1</td>
              <td style="border:none;" align="char" char=".">9.11</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref43">43</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">13</td>
              <td style="border:none;" align="left">GFWGKLFKLGLHGIGLLHLHL</td>
              <td style="border:none;" align="char" char=".">503.45</td>
              <td style="border:none;" align="char" char=".">0.16</td>
              <td style="border:none;" align="char" char=".">0.75</td>
              <td style="border:none;" align="char" char=".">3.5</td>
              <td style="border:none;" align="char" char=".">10.02</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref44">44</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">14</td>
              <td style="border:none;" align="left">GRRKRKWLRRIGKGVKIIGGAALDHL</td>
              <td style="border:none;" align="char" char=".">502.60</td>
              <td style="border:none;" align="char" char=".">–0.31</td>
              <td style="border:none;" align="char" char=".">–0.56</td>
              <td style="border:none;" align="char" char=".">8.5</td>
              <td style="border:none;" align="char" char=".">12.19</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref44">44</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">15</td>
              <td style="border:none;" align="left">FLGGLIKIVPAMICAVTKKC</td>
              <td style="border:none;" align="char" char=".">502.16</td>
              <td style="border:none;" align="char" char=".">0.12</td>
              <td style="border:none;" align="char" char=".">1.33</td>
              <td style="border:none;" align="char" char=".">3</td>
              <td style="border:none;" align="char" char=".">9.42</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref45">45</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">16</td>
              <td style="border:none;" align="left">FLGAVLKVAGKLVPAAICKISKKC</td>
              <td style="border:none;" align="char" char=".">501.22</td>
              <td style="border:none;" align="char" char=".">0.03</td>
              <td style="border:none;" align="char" char=".">1.01</td>
              <td style="border:none;" align="char" char=".">5</td>
              <td style="border:none;" align="char" char=".">9.91</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref46">46</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">17</td>
              <td style="border:none;" align="left">FLQHIIGALGHLF</td>
              <td style="border:none;" align="char" char=".">498.75</td>
              <td style="border:none;" align="char" char=".">0.24</td>
              <td style="border:none;" align="char" char=".">1.22</td>
              <td style="border:none;" align="char" char=".">1</td>
              <td style="border:none;" align="char" char=".">7.26</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref47">47</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">18</td>
              <td style="border:none;" align="left">KWKSFIKKLTKKFLHSAKKF</td>
              <td style="border:none;" align="char" char=".">496.84</td>
              <td style="border:none;" align="char" char=".">–0.27</td>
              <td style="border:none;" align="char" char=".">–0.73</td>
              <td style="border:none;" align="char" char=".">8.5</td>
              <td style="border:none;" align="char" char=".">10.85</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref48">48</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">19</td>
              <td style="border:none;" align="left">GGGCGIGGGCGPIGDCGPIGGGCGPIGGGCGPVGGW</td>
              <td style="border:none;" align="char" char=".">496.31</td>
              <td style="border:none;" align="char" char=".">0.17</td>
              <td style="border:none;" align="char" char=".">0.43</td>
              <td style="border:none;" align="char" char=".">–1</td>
              <td style="border:none;" align="char" char=".">3.8</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">20</td>
              <td style="border:none;" align="left">FLPFIAGMAAKFLPKIFCAISKK</td>
              <td style="border:none;" align="char" char=".">495.05</td>
              <td style="border:none;" align="char" char=".">0.1</td>
              <td style="border:none;" align="char" char=".">1.04</td>
              <td style="border:none;" align="char" char=".">4</td>
              <td style="border:none;" align="char" char=".">10.05</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref42">42</xref>)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t3fn1">
            <label>a</label>
            <p>PCP1 = hydrophobicity, PCP2 = hydropathicity,
PCP3 = charge, PCP4 = pI.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="tbl4" position="float">
        <label>Table 4</label>
        <caption>
          <title>Top 20 Non-Anti-MRSA Peptides Having
the Lowest <italic>S</italic>(<italic>P</italic>) along with Their
Important Physicochemical Properties<xref rid="t4fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">#</th>
              <th style="border:none;" align="center">peptide sequence</th>
              <th style="border:none;" align="center" char=".">score</th>
              <th style="border:none;" align="center" char=".">PCP1</th>
              <th style="border:none;" align="center" char=".">PCP2</th>
              <th style="border:none;" align="center" char=".">PCP3</th>
              <th style="border:none;" align="center" char=".">PCP4</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">1</td>
              <td style="border:none;" align="left">VNVEALQKVVDES</td>
              <td style="border:none;" align="char" char=".">190.00</td>
              <td style="border:none;" align="char" char=".">–0.12</td>
              <td style="border:none;" align="char" char=".">0.01</td>
              <td style="border:none;" align="char" char=".">–2</td>
              <td style="border:none;" align="char" char=".">4.14</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">2</td>
              <td style="border:none;" align="left">RAYREDELIQLL</td>
              <td style="border:none;" align="char" char=".">198.55</td>
              <td style="border:none;" align="char" char=".">–0.28</td>
              <td style="border:none;" align="char" char=".">–0.51</td>
              <td style="border:none;" align="char" char=".">–1</td>
              <td style="border:none;" align="char" char=".">4.68</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left">KPLDDTLILEMA</td>
              <td style="border:none;" align="char" char=".">205.64</td>
              <td style="border:none;" align="char" char=".">–0.04</td>
              <td style="border:none;" align="char" char=".">0.22</td>
              <td style="border:none;" align="char" char=".">–2</td>
              <td style="border:none;" align="char" char=".">4.03</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left">PHLVIPEIEAIATQTLVEMEAEGLN</td>
              <td style="border:none;" align="char" char=".">207.29</td>
              <td style="border:none;" align="char" char=".">0.03</td>
              <td style="border:none;" align="char" char=".">0.3</td>
              <td style="border:none;" align="char" char=".">–4.5</td>
              <td style="border:none;" align="char" char=".">3.98</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">5</td>
              <td style="border:none;" align="left">DADLYTPSIHLYFNDDLTEL</td>
              <td style="border:none;" align="char" char=".">216.16</td>
              <td style="border:none;" align="char" char=".">–0.07</td>
              <td style="border:none;" align="char" char=".">–0.3</td>
              <td style="border:none;" align="char" char=".">–4.5</td>
              <td style="border:none;" align="char" char=".">3.71</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">6</td>
              <td style="border:none;" align="left">ADDLLNERYEAVG</td>
              <td style="border:none;" align="char" char=".">218.33</td>
              <td style="border:none;" align="char" char=".">–0.2</td>
              <td style="border:none;" align="char" char=".">–0.59</td>
              <td style="border:none;" align="char" char=".">–3</td>
              <td style="border:none;" align="char" char=".">3.92</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">7</td>
              <td style="border:none;" align="left">LEMNVNQLSKETSELKALAVELVEENVALQ</td>
              <td style="border:none;" align="char" char=".">219.10</td>
              <td style="border:none;" align="char" char=".">–0.12</td>
              <td style="border:none;" align="char" char=".">–0.05</td>
              <td style="border:none;" align="char" char=".">–4</td>
              <td style="border:none;" align="char" char=".">4.21</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">8</td>
              <td style="border:none;" align="left">TRLQFQALDSTQFATAQGEVPELVLVNPPRR</td>
              <td style="border:none;" align="char" char=".">220.07</td>
              <td style="border:none;" align="char" char=".">–0.18</td>
              <td style="border:none;" align="char" char=".">–0.34</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="char" char=".">6.53</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">9</td>
              <td style="border:none;" align="left">FDTVVGRDTLIEPNVV</td>
              <td style="border:none;" align="char" char=".">222.87</td>
              <td style="border:none;" align="char" char=".">–0.04</td>
              <td style="border:none;" align="char" char=".">0.35</td>
              <td style="border:none;" align="char" char=".">–2</td>
              <td style="border:none;" align="char" char=".">4.03</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">10</td>
              <td style="border:none;" align="left">EDEDEEEILDHEMREIVHIQAGQCGN</td>
              <td style="border:none;" align="char" char=".">223.40</td>
              <td style="border:none;" align="char" char=".">–0.26</td>
              <td style="border:none;" align="char" char=".">–1.09</td>
              <td style="border:none;" align="char" char=".">–8</td>
              <td style="border:none;" align="char" char=".">4</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">11</td>
              <td style="border:none;" align="left">ELVRSKNPDMDE</td>
              <td style="border:none;" align="char" char=".">223.91</td>
              <td style="border:none;" align="char" char=".">–0.4</td>
              <td style="border:none;" align="char" char=".">–1.42</td>
              <td style="border:none;" align="char" char=".">–2</td>
              <td style="border:none;" align="char" char=".">4.32</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">12</td>
              <td style="border:none;" align="left">VPGAEGQYFAYIAYDLDLFEPGSI</td>
              <td style="border:none;" align="char" char=".">225.09</td>
              <td style="border:none;" align="char" char=".">0.07</td>
              <td style="border:none;" align="char" char=".">0.21</td>
              <td style="border:none;" align="char" char=".">–4</td>
              <td style="border:none;" align="char" char=".">3.44</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">13</td>
              <td style="border:none;" align="left">QDIELCPECFSAG</td>
              <td style="border:none;" align="char" char=".">225.75</td>
              <td style="border:none;" align="char" char=".">–0.04</td>
              <td style="border:none;" align="char" char=".">0.08</td>
              <td style="border:none;" align="char" char=".">–3</td>
              <td style="border:none;" align="char" char=".">3.58</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">14</td>
              <td style="border:none;" align="left">CGVIDLAELVRNAHP</td>
              <td style="border:none;" align="char" char=".">229.43</td>
              <td style="border:none;" align="char" char=".">–0.04</td>
              <td style="border:none;" align="char" char=".">0.4</td>
              <td style="border:none;" align="char" char=".">–0.5</td>
              <td style="border:none;" align="char" char=".">5.33</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">15</td>
              <td style="border:none;" align="left">DREGTLFIEESDNNNVWTTTA</td>
              <td style="border:none;" align="char" char=".">229.55</td>
              <td style="border:none;" align="char" char=".">–0.22</td>
              <td style="border:none;" align="char" char=".">–0.92</td>
              <td style="border:none;" align="char" char=".">–4</td>
              <td style="border:none;" align="char" char=".">3.84</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">16</td>
              <td style="border:none;" align="left">IAEQVASFQEEK</td>
              <td style="border:none;" align="char" char=".">230.09</td>
              <td style="border:none;" align="char" char=".">–0.17</td>
              <td style="border:none;" align="char" char=".">–0.55</td>
              <td style="border:none;" align="char" char=".">–2</td>
              <td style="border:none;" align="char" char=".">4.26</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">17</td>
              <td style="border:none;" align="left">SSDPASSEMLSPSTQLLFYETSASFSTEV</td>
              <td style="border:none;" align="char" char=".">230.89</td>
              <td style="border:none;" align="char" char=".">–0.07</td>
              <td style="border:none;" align="char" char=".">–0.15</td>
              <td style="border:none;" align="char" char=".">–4</td>
              <td style="border:none;" align="char" char=".">3.51</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">18</td>
              <td style="border:none;" align="left">LQYEPEDPMSSNGDKLLVRSKF</td>
              <td style="border:none;" align="char" char=".">230.90</td>
              <td style="border:none;" align="char" char=".">–0.25</td>
              <td style="border:none;" align="char" char=".">–0.88</td>
              <td style="border:none;" align="char" char=".">–1</td>
              <td style="border:none;" align="char" char=".">4.79</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">19</td>
              <td style="border:none;" align="left">NLTLTLDKGTLHQEVNLV</td>
              <td style="border:none;" align="char" char=".">232.88</td>
              <td style="border:none;" align="char" char=".">–0.08</td>
              <td style="border:none;" align="char" char=".">0.02</td>
              <td style="border:none;" align="char" char=".">–0.5</td>
              <td style="border:none;" align="char" char=".">5.33</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">20</td>
              <td style="border:none;" align="left">YRVDSDATHSPMFHQVEGL</td>
              <td style="border:none;" align="char" char=".">233.11</td>
              <td style="border:none;" align="char" char=".">–0.17</td>
              <td style="border:none;" align="char" char=".">–0.62</td>
              <td style="border:none;" align="char" char=".">–1</td>
              <td style="border:none;" align="char" char=".">5.22</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t4fn1">
            <label>a</label>
            <p>PCP1 = hydrophobicity, PCP2 = hydropathicity,
PCP3 = charge, PCP4 = pI.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>From <xref rid="tbl3" ref-type="other">Tables <xref rid="tbl3" ref-type="other">3</xref></xref> and <xref rid="tbl4" ref-type="other">4</xref>, several observations can be
made: (i) the anti-MRSA
scores of all top 20 high-potential anti-MRSA peptides were greater
than 495, while the anti-MRSA scores of all top 20 non-anti-MRSA peptides
were lower than 232, where the threshold value was set to 399; (ii)
the anti-MRSA scores derived from our proposed approach SCMRSA, showed
a high correlation with the hydrophobicity and charge properties,
and (iii) 16 out of 20 potential anti-MRSA peptides having the highest
anti-MRSA score exhibited high hydrophobicity and low positive charge
(+1 to +5) (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>), while all the top 20 non-anti-MRSA peptides having lowest anti-MRSA
scores (lower than 233) prefer to exhibit negative charge and low
hydrophobicity (<xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref>). Mishra and Wang.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> studied the most
critical parameters (e.g., composition, peptide hydrophobic content,
and net charge) of potent anti-MRSA peptides using a database filtering
technology (DFT). The researchers found that high hydrophobicity and
low cationicity (a net charge molecule of +1) were two critical parameters
for designing potential anti-MRSA peptides. Taken together, this analysis
revealed that high hydrophobicity and low cationicity could be important
properties in the design and development of novel anti-MRSA peptides.</p>
      <p>Furthermore, <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> highlights that the top-five high-potential anti-MRSA peptides contained
FLKAIKKFGKEFKKIGAKLK (Omega 76 (Ω76)), FLPAALAGIGGILGKLF (temporin-SHd),
KRIGLIRLIGKILRGLRRLG (Saha-CATH5), FLPLIAGLFGKIF (temporin-PF) and
FLSAITSILGKFF (temporin-1Spa) having anti-MRSA scores higher than
528. To be specific, Ω76 was considered as the most potential
anti-MRSA peptide as indicated by the anti-MRSA score. Previously,
Ω76 is well recognized as a helical peptide exhibiting a 50%
minimal bactericidal concentration (MBC<sub>50</sub>) of 16 mg/liter
for MRSA without toxicity against HeLa cells, even at the highest
concentration tested (128 mg/liter). In addition, Ω76, which
was designed using the Heligrapher software package, has reported
antimicrobial activity against multidrug-resistant ESKAPE pathogens,
namely, <italic>Enterococcus faecium</italic>, <italic>Staphylococcus aureus</italic>, <italic>Klebsiella
pneumoniae</italic>, <italic>Acinetobacter baumannii</italic>, <italic>Enterobacter</italic> spp, and <italic>Pseudomonas aeruginosa</italic><italic>.</italic>(<xref ref-type="bibr" rid="ref33">33</xref>) Interestingly, three out of the top-five high-potential
anti-MRSA peptides are temporins derived from a frog-derived AMP family.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> Several studies mentioned that temporins were
able to exhibit greater potencies against Gram-positive bacteria,
such as <italic>S. aureus</italic> as compared to Gram-negative
bacteria.<sup><xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref50">50</xref></sup> Moreover,
temporin-SHd and Tasmanian devil cathelicidin Saha-CATH5 were ranked
as the second and third potential anti-MRSA peptides, respectively.
Temporin-SHd in the frog skin of <italic>Pelophylax saharicus</italic> was highly active against MRSA (ATCC 43300 and ATCC BAA-44) with
a minimal inhibitory concentration (MIC) of 6.25 μM.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> Likewise, temporin-PF identified from <italic>Pelophylax fukienensis</italic> displayed antimicrobial activity
against MRSA (NCTC 12493), while it was ineffective against Gram-negative
strains, such as <italic>Escherichia coli</italic> (NCTC
10418), <italic>P. aeruginosa</italic> (ATCC 27853),
and <italic>K. pneumoniae</italic> (ATCC 43816), at
a concentration of up to 128 μM.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> However, Saha-CATH5 also exhibited a strong bactericidal activity
against MRSA with a MIC of 32 μg/mL, while a concentration of
64 μg/mL had no effect against <italic>P. aeruginosa</italic> (ATCC 27853).<sup><xref ref-type="bibr" rid="ref35">35</xref></sup></p>
    </sec>
    <sec id="sec3.4">
      <label>3.4</label>
      <title>Characterization of Anti-MRSA Peptides Using
SCMRSA-Derived Propensity Scores</title>
      <p>Here, the propensities of
amino acids and dipeptides to be anti-MRSA peptides (PS) were utilized
to characterize the biochemical and biophysical properties of anti-MRSA
peptides. <xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref> displays
the propensity scores of amino acids and the amino acid compositions
(%). Amino acids having the highest propensity scores are deemed to
be the most important in anti-MRSA peptides. As can be seen from <xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>, Lys, Gly, Cys, Trp,
and Ile with the corresponding scores of 448, 427, 410, 376, and 374,
respectively, are the top five amino acids exhibiting the largest
propensities, while Glu, Asp, Met, Gln, and Pro with the corresponding
scores of 196, 200, 257, 264, and 282, respectively, are the top five
amino acids exhibiting the lowest propensities. The most preferred
amino acid in natural AMPs that have been reported in the AMP database
(APD) are Gly, Ser, and Lys.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Although,
Gly and Lys are also dominating residues in both anti-MRSA peptides
and natural AMPs. Interestingly, Ser has been found at number 11 in
rank of the propensities in this study. Moreover, anti-MRSA peptides
displayed a significantly difference from non-anti-MRSA peptides in
terms of these 10 important amino acids at a level of <italic>p</italic> &lt; 0.01 (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>).</p>
      <fig id="fig6" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Boxplots of amino acid compositions of 20 amino acids for positives
and negatives. <italic>X</italic>- and <italic>Y</italic>-axes represent
20 amino acids along with their <italic>p</italic>-value.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_0007" id="gr6" position="float"/>
      </fig>
      <table-wrap id="tbl5" position="float">
        <label>Table 5</label>
        <caption>
          <title>Propensity Scores of 20 Amino Acids
to be Anti-MRSA Peptides (PS) along with Amino Acid Compositions of
Anti-MRSA and Non-Anti-MRSA Peptides</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="left"/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">amino acid</th>
              <th style="border:none;" align="center">PS (rank)</th>
              <th style="border:none;" align="center" char=".">anti-MRSA</th>
              <th style="border:none;" align="center" char=".">non-anti-MRSA</th>
              <th style="border:none;" align="center">difference (rank)</th>
              <th style="border:none;" align="center" char="."><italic>p</italic>-value</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">K-Lys</td>
              <td style="border:none;" align="left">448(1)</td>
              <td style="border:none;" align="char" char=".">0.111</td>
              <td style="border:none;" align="char" char=".">0.058</td>
              <td style="border:none;" align="left">0.054(1)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">G-Gly</td>
              <td style="border:none;" align="left">427(2)</td>
              <td style="border:none;" align="char" char=".">0.111</td>
              <td style="border:none;" align="char" char=".">0.071</td>
              <td style="border:none;" align="left">0.040(2)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">C-Cys</td>
              <td style="border:none;" align="left">410(3)</td>
              <td style="border:none;" align="char" char=".">0.046</td>
              <td style="border:none;" align="char" char=".">0.014</td>
              <td style="border:none;" align="left">0.032(3)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">W-Trp</td>
              <td style="border:none;" align="left">376(4)</td>
              <td style="border:none;" align="char" char=".">0.023</td>
              <td style="border:none;" align="char" char=".">0.011</td>
              <td style="border:none;" align="left">0.012(7)</td>
              <td style="border:none;" align="char" char=".">0.007</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">I-Ile</td>
              <td style="border:none;" align="left">374(5)</td>
              <td style="border:none;" align="char" char=".">0.082</td>
              <td style="border:none;" align="char" char=".">0.060</td>
              <td style="border:none;" align="left">0.022(6)</td>
              <td style="border:none;" align="char" char=".">0.001</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">R-Arg</td>
              <td style="border:none;" align="left">367(6)</td>
              <td style="border:none;" align="char" char=".">0.062</td>
              <td style="border:none;" align="char" char=".">0.056</td>
              <td style="border:none;" align="left">0.006(9)</td>
              <td style="border:none;" align="char" char=".">0.440</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">F-Phe</td>
              <td style="border:none;" align="left">366(7)</td>
              <td style="border:none;" align="char" char=".">0.064</td>
              <td style="border:none;" align="char" char=".">0.038</td>
              <td style="border:none;" align="left">0.026(5)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">L-Leu</td>
              <td style="border:none;" align="left">336(8)</td>
              <td style="border:none;" align="char" char=".">0.126</td>
              <td style="border:none;" align="char" char=".">0.096</td>
              <td style="border:none;" align="left">0.030(4)</td>
              <td style="border:none;" align="char" char=".">0.005</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">H-His</td>
              <td style="border:none;" align="left">330(9)</td>
              <td style="border:none;" align="char" char=".">0.029</td>
              <td style="border:none;" align="char" char=".">0.021</td>
              <td style="border:none;" align="left">0.007(8)</td>
              <td style="border:none;" align="char" char=".">0.168</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">A-Ala</td>
              <td style="border:none;" align="left">315(10)</td>
              <td style="border:none;" align="char" char=".">0.079</td>
              <td style="border:none;" align="char" char=".">0.082</td>
              <td style="border:none;" align="left">–0.003(10)</td>
              <td style="border:none;" align="char" char=".">0.683</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">S-Ser</td>
              <td style="border:none;" align="left">312(11)</td>
              <td style="border:none;" align="char" char=".">0.055</td>
              <td style="border:none;" align="char" char=".">0.069</td>
              <td style="border:none;" align="left">–0.014(13)</td>
              <td style="border:none;" align="char" char=".">0.013</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Y-Tyr</td>
              <td style="border:none;" align="left">299(12)</td>
              <td style="border:none;" align="char" char=".">0.016</td>
              <td style="border:none;" align="char" char=".">0.029</td>
              <td style="border:none;" align="left">–0.014(12)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">T-Thr</td>
              <td style="border:none;" align="left">298(13)</td>
              <td style="border:none;" align="char" char=".">0.039</td>
              <td style="border:none;" align="char" char=".">0.051</td>
              <td style="border:none;" align="left">–0.012(11)</td>
              <td style="border:none;" align="char" char=".">0.025</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">N-Asn</td>
              <td style="border:none;" align="left">297(14)</td>
              <td style="border:none;" align="char" char=".">0.021</td>
              <td style="border:none;" align="char" char=".">0.040</td>
              <td style="border:none;" align="left">–0.020(17)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">V-Val</td>
              <td style="border:none;" align="left">288(15)</td>
              <td style="border:none;" align="char" char=".">0.054</td>
              <td style="border:none;" align="char" char=".">0.072</td>
              <td style="border:none;" align="left">–0.018(15)</td>
              <td style="border:none;" align="char" char=".">0.001</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">P-Pro</td>
              <td style="border:none;" align="left">282(16)</td>
              <td style="border:none;" align="char" char=".">0.029</td>
              <td style="border:none;" align="char" char=".">0.046</td>
              <td style="border:none;" align="left">–0.017(14)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Q-Gln</td>
              <td style="border:none;" align="left">264(17)</td>
              <td style="border:none;" align="char" char=".">0.016</td>
              <td style="border:none;" align="char" char=".">0.039</td>
              <td style="border:none;" align="left">–0.023(18)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-Met</td>
              <td style="border:none;" align="left">257(18)</td>
              <td style="border:none;" align="char" char=".">0.008</td>
              <td style="border:none;" align="char" char=".">0.026</td>
              <td style="border:none;" align="left">–0.018(16)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">D-Asp</td>
              <td style="border:none;" align="left">200(19)</td>
              <td style="border:none;" align="char" char=".">0.012</td>
              <td style="border:none;" align="char" char=".">0.053</td>
              <td style="border:none;" align="left">–0.040(19)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">E-Glu</td>
              <td style="border:none;" align="left">196(20)</td>
              <td style="border:none;" align="char" char=".">0.017</td>
              <td style="border:none;" align="char" char=".">0.068</td>
              <td style="border:none;" align="left">–0.051(20)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">R</td>
              <td style="border:none;" align="left">1.000</td>
              <td style="border:none;" align="char" char=".">0.683</td>
              <td style="border:none;" align="char" char=".">–0.072</td>
              <td style="border:none;" align="left">0.953</td>
              <td style="border:none;" align="char" char="."> </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Xie et al.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> analyzed the
temporin-GHa
(GHa) peptide using a combination between the template-based design
coupled with the database-assisted design. Their analysis demonstrated
that the GHa peptide exhibited stronger antimicrobial activity against
Gram-positive bacteria, such as MRSA, as compared to Gram-negative
bacteria. In addition, the results showed that Lys, Gly, Arg, and
Leu were found to be abundant in AMPs, while Asp and Glu were relatively
less abundant in temporins. These results are quite consistent with
the SCMRSA-derived propensities of amino acids, as recorded in <xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>. As can be seen from
further in <xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>,
the ranks of the propensities for Lys, Gly, Arg, and Leu were 1, 2,
6, and 8, respectively, while the rank of the propensities for Asp
and Glu was 19 and 20. Moreover, substitution of His with Lys at both
ends of the GHa peptide to design the single-point or multi-point
mutation peptides as GHaK, GHa4K, and GHa11K could enhance its antibacterial
activity against MRSA (ATCC 43300) and MRSA-2 (isolate).</p>
      <p>The
same results were also found in the study of Zouhir et al.,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> where they showed that 118 peptides with high
activity against MRSA at low MIC were determined using their physicochemical
data. For &gt;80% of all anti-MRSA peptides, they consisted of Lys,
Gly,
Ile, and Leu, whereas Met and Asp were rarely found in Zouhir et al.’s
study. Moreover, newly designed peptide S2, constructed by modifying
the autoinducing peptide of <italic>S. aureus</italic> and adding a disulfide bond (Cys1–Cys6), was able to improve
the antimicrobial selectivity against <italic>S. aureus</italic>, both in vitro and in vivo<italic>.</italic><sup><xref ref-type="bibr" rid="ref53">53</xref></sup> This study mentioned that the disulfide bonds from Cys
played an important role in the targeting activity against <italic>S. aureus</italic>. Although Trp is found to be less frequently
deployed on average in natural AMPs, a triple Trp (WWW) motif has
been reported as a critical determinant in the Trp-rich peptide, TetraF2W-RK
(WWWLRKIW-amide) for their bactericidal activity against MRSA (USA300)
and their disruption of bacterial biofilms.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p>
    </sec>
    <sec id="sec3.5">
      <label>3.5</label>
      <title>Characterization of Anti-MRSA Peptides Using
Informative PCPs</title>
      <p>Impressively, SCMRSA was able to identify
informative PCPs in order to provide insights into the functional
mechanisms of anti-MRSA peptides.<sup><xref ref-type="bibr" rid="ref55">55</xref>−<xref ref-type="bibr" rid="ref58">58</xref></sup> The 20 top-ranked informative
PCPs are listed in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04305/suppl_file/ao2c04305_si_001.pdf">Supporting Information</ext-link>, Table S10. KLEP840101, FINA910104, ZASB820101, ZIMJ680104, and
ROBB760111 with the corresponding R values of 0.709, 0.644, 0.617,
0.610, and 0.557, respectively, were considered as the five top-ranked
PCPs herein. <xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref> lists the selected three PCPs for analyzing anti-MRSA peptides,
including KLEP840101 (<italic>R</italic> = 0.709), ZIMJ680104 (<italic>R</italic> = 0.610), and WIMW960101 (<italic>R</italic> = 0.523).</p>
      <table-wrap id="tbl6" position="float">
        <label>Table 6</label>
        <caption>
          <title>Two Important Physicochemical Property
(PCP)-Derived from SCMRSA</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">amino acid</th>
              <th style="border:none;" align="center">PS (rank)</th>
              <th style="border:none;" align="center" char=".">KLEP840101</th>
              <th style="border:none;" align="center">ZIMJ680104
(rank)</th>
              <th style="border:none;" align="center">WIMW960101\ (rank)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">K-Lys</td>
              <td style="border:none;" align="left">448(1)</td>
              <td style="border:none;" align="char" char=".">1</td>
              <td style="border:none;" align="left">9.74(2)</td>
              <td style="border:none;" align="left">4.08(12)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">G-Gly</td>
              <td style="border:none;" align="left">427(2)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.97(8)</td>
              <td style="border:none;" align="left">4.49(6)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">C-Cys</td>
              <td style="border:none;" align="left">410(3)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.05(18)</td>
              <td style="border:none;" align="left">3.02(19)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">W-Trp</td>
              <td style="border:none;" align="left">376(4)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.89(10)</td>
              <td style="border:none;" align="left">2.23(20)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">I-Ile</td>
              <td style="border:none;" align="left">374(5)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">6.02(5)</td>
              <td style="border:none;" align="left">5.38(2)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">R-Arg</td>
              <td style="border:none;" align="left">367(6)</td>
              <td style="border:none;" align="char" char=".">1</td>
              <td style="border:none;" align="left">10.76(1)</td>
              <td style="border:none;" align="left">4.24(8)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">F-Phe</td>
              <td style="border:none;" align="left">366(7)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.48(16)</td>
              <td style="border:none;" align="left">4.08(13)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">L-Leu</td>
              <td style="border:none;" align="left">336(8)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.98(7)</td>
              <td style="border:none;" align="left">4.52(5)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">H-His</td>
              <td style="border:none;" align="left">330(9)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">7.59(3)</td>
              <td style="border:none;" align="left">3.77(17)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">A-Ala</td>
              <td style="border:none;" align="left">315(10)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">6(6)</td>
              <td style="border:none;" align="left">4.81(4)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">S-Ser</td>
              <td style="border:none;" align="left">312(11)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.68(12)</td>
              <td style="border:none;" align="left">4.48(7)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Y-Tyr</td>
              <td style="border:none;" align="left">299(12)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.66(14)</td>
              <td style="border:none;" align="left">3.83(15)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">T-Thr</td>
              <td style="border:none;" align="left">298(13)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.66(13)</td>
              <td style="border:none;" align="left">3.8(16)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">N-Asn</td>
              <td style="border:none;" align="left">297(14)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.41(17)</td>
              <td style="border:none;" align="left">3.67(18)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">V-Val</td>
              <td style="border:none;" align="left">288(15)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.96(9)</td>
              <td style="border:none;" align="left">3.91(14)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">P-Pro</td>
              <td style="border:none;" align="left">282(16)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">6.3(4)</td>
              <td style="border:none;" align="left">4.12(10)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Q-Gln</td>
              <td style="border:none;" align="left">264(17)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.65(15)</td>
              <td style="border:none;" align="left">4.11(11)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-Met</td>
              <td style="border:none;" align="left">257(18)</td>
              <td style="border:none;" align="char" char=".">0</td>
              <td style="border:none;" align="left">5.74(11)</td>
              <td style="border:none;" align="left">4.18(9)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">D-Asp</td>
              <td style="border:none;" align="left">200(19)</td>
              <td style="border:none;" align="char" char=".">–1</td>
              <td style="border:none;" align="left">2.77(20)</td>
              <td style="border:none;" align="left">6.1(1)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">E-Glu</td>
              <td style="border:none;" align="left">196(20)</td>
              <td style="border:none;" align="char" char=".">–1</td>
              <td style="border:none;" align="left">3.22(19)</td>
              <td style="border:none;" align="left">5.19(3)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>R</italic>
              </td>
              <td style="border:none;" align="left">1.000</td>
              <td style="border:none;" align="char" char=".">0.709</td>
              <td style="border:none;" align="left">0.610</td>
              <td style="border:none;" align="left">0.523</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>KLEP840101, which is denoted as the “Net charge”,<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> exhibited the highest positive correlation of
0.709. From <xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref>, we notice that Lys and Arg are both positively charged residues,
while Asp and Glu are both negatively charged residues. In addition,
Lys, Arg, Asp, and Glu were ranked the 1st, 6th, 19th and 20th, respectively,
important amino acids based on the propensities. The high positive <italic>R</italic> value of KLEP840101 suggested that anti-MRSA peptides
favored positively charged amino acids. As previously mentioned, Zouhir
et al.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> analyzed the physicochemical data
of 118 peptides derived from the APD<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> database
with low MIC values against MRSA. Their results showed that the majority
of anti-MRSA peptides were cationic amphipathic proteins containing
a high number of cationic Arg and Lys residues. Moreover, 268 AMPs
with anti-G+ (Gram positive bacteria) activity in APD were analyzed
using DFT. This study found that the most frequently occurring amino
acids of anti-G+ peptides were Leu, Gly, and Lys, which also displayed
a net charge molecule of +1 based on the positively charged amino
acid, such as Lys.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup></p>
      <p>ZIMJ680104,
which is denoted as the “Isoelectric point”,<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> had a high positive correlation of 0.610. Zimmerman
et al.<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> studied the side chain physical
properties, such as an isoelectric point (pI) of 20 amino acids. An
isoelectric point is the pH of a solution at which the net charge
of a protein becomes zero. If the side chain of an amino acid is basic,
the pI shows a higher pH. However, if the side chain is acidic, the
pI shows a lower pH. The high positive <italic>R</italic> value between
pI and the propensity scores of amino acids suggested that anti-MRSA
peptides favored basic amino acid side chains (high pH value). There
are three amino acids containing basic side chains, including Lys,
Arg, and His. As could be seen in <xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref>, the ranks of propensity scores (PS, pI)
for Lys, Arg, and His are (1, 2), (6, 1), and (9, 3) respectively.
Moreover, the pI of 19 out of the 20 high-potential anti-MRSA peptides
were higher than 9. On the other hand, the pI of all 20 non-anti-MRSA
peptides were lower than 6. In a previous study, an average pI derived
from 118 peptides with high activity against MRSA also showed a higher
pH preference (an average mean of 11.07).<sup><xref ref-type="bibr" rid="ref52">52</xref></sup></p>
      <p>WIMW960101, which is described as the “interfacial
values”,<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> had a positive correlation
of 0.523. Wimley
and White.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> determined the hydrophobicity
scale for the partitioning of amino acid residues of AcWl-X-LL peptides
into electrically neutral (zwitterionic) membrane interfaces from
palmitoyloleoylphosphatidylcholine (POPC). The result displayed the
whole-residue interfacial values (side chain plus peptide backbone)
fall into three distinct classes and the aromatic amino acids (i.e.,
Phe, Trp, and Tyr) are highly favorable in membrane interfaces. From <xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref>, it can be observed
that two aromatic amino acids (Trp and Phe) are found in the 10 top-ranked
amino acids with the highest propensities. To be specific, the ranks
of propensities (PS and interfacial values) for Trp and Phe were (4,
1) and (7, 2), respectively. It is well recognized that all aromatic
amino acids are generally hydrophobic. This result suggested that
the anti-MRSA peptides favor aromatic and hydrophobic amino acids.
As described earlier, Zarena et al.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> analyzed
the composition of Trp-rich peptide and TetraF2W-RK peptide with high
antimicrobial activity against MRSA (USA300) and found that a Trp
triplet (WWW) motif played a critical role in killing and disrupting
the performance of bacterial biofilms. Furthermore, 118 peptides with
low MIC values against MRSA were analyzed for their amino acid composition.
It was discovered that at least 65% of all peptides contained Phe,
which is an aromatic amino acid.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup></p>
    </sec>
    <sec id="sec3.6">
      <label>3.6</label>
      <title>Implementation and Utility of SCMRSA</title>
      <p>SCMRSA is the first open-source computational tool developed for
identifying and characterizing anti-MRSA peptides by employing sequence
information without the use of 3D structural information. Therefore,
in order to serve the scientific community, we have employed our best
SCM model as an easy-to-use web server (named SCMRSA). The SCMRSA
web server could be beneficial for the large-scale identification
of peptides having anti-MRSA activity. It could be stated that peptides
with the highest anti-MRSA score were deemed to be potential anti-MRSA
peptides and could then be prioritized for experimental testing. An
easy-to-use webserver of SCMRSA is freely accessible at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pmlabstack.pythonanywhere.com/SCMRSA">http://pmlabstack.pythonanywhere.com/SCMRSA</uri>.</p>
    </sec>
  </sec>
  <sec id="sec4">
    <label>4</label>
    <title>Conclusions</title>
    <p>This study presents SCMRSA,
an interpretable ML-based approach,
which makes use of the SCM algorithm in conjunction with the propensities
of amino acids and dipeptides. To the best of our knowledge, SCMRSA
is the first computational tool for the identification and characterization
of anti-MRSA peptides using only sequence information without the
use of 3D structural information. When comparing SCMRSA with other
conventional ML-based classifiers (i.e., DT, KNN, LR, NB, and PLS)
on the independent test data set, SCMRSA was more effective and outperformed
the compared ML-based classifiers, with an ACC of 0.960, MCC of 0.848,
and AUC of 0.986. In addition, the SCMRSA-derived propensity scores
were employed to provide insights into the biophysical and biochemical
properties of anti-MRSA. Finally, in order to serve the community-wide
use of the proposed SCMRSA, we established a user-friendly web server
online at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pmlabstack.pythonanywhere.com/SCMRSA">http://pmlabstack.pythonanywhere.com/SCMRSA</uri>. SCMRSA is anticipated
to be an open-sourced and useful tool for facilitating the user convenience
to determine potential anti-MRSA peptides for follow-up experimental
validation.</p>
  </sec>
</body>
<back>
  <notes id="notes1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsomega.2c04305?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsomega.2c04305</ext-link>.<list id="silist" list-type="simple"><list-item><p>Performance evaluations of SCMRSA and several ML-based
classifiers and 20 top-ranked informative PCPs (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04305/suppl_file/ao2c04305_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04305_si_001.pdf">
        <caption>
          <p>ao2c04305_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="COI-statement" id="NOTES-d14e2198-autogenerated">
    <p>The authors
declare no
competing financial interest.</p>
  </notes>
  <notes notes-type="" id="notes2">
    <title>Notes</title>
    <p>The datasets
used in the current study are available
at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pmlabstack.pythonanywhere.com/SCMRSA">http://pmlabstack.pythonanywhere.com/SCMRSA</uri>.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This work was fully supported by College of Arts,
Media, and Technology, Chiang Mai University, and partially supported
by Chiang Mai University and Mahidol University. In addition, computational
resources were supported by Information Technology Service Center
(ITSC) of Chiang Mai University.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Gould</surname><given-names>D.</given-names></name>; <name><surname>Chamberlaine</surname><given-names>A.</given-names></name><article-title>Staphylococcus aureus: a review of the literature</article-title>. <source>J. Clin. Nurs.</source><year>1995</year>, <volume>4</volume>, <fpage>5</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2702.1995.tb00004.x</pub-id>.<pub-id pub-id-type="pmid">7704377</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Lowy</surname><given-names>F. D.</given-names></name><article-title>Staphylococcus
aureusInfections</article-title>. <source>N. Engl. J. Med.</source><year>1998</year>, <volume>339</volume>, <fpage>520</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1056/nejm199808203390806</pub-id>.<pub-id pub-id-type="pmid">9709046</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Gordon</surname><given-names>R. J.</given-names></name>; <name><surname>Lowy</surname><given-names>F. D.</given-names></name><article-title>Pathogenesis of
methicillin-resistant Staphylococcus
aureus infection</article-title>. <source>Clin. Infect. Dis.</source><year>2008</year>, <volume>46</volume>, <fpage>S350</fpage>–<lpage>S359</lpage>. <pub-id pub-id-type="doi">10.1086/533591</pub-id>.<pub-id pub-id-type="pmid">18462090</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Turner</surname><given-names>N. A.</given-names></name>; <name><surname>Sharma-Kuinkel</surname><given-names>B. K.</given-names></name>; <name><surname>Maskarinec</surname><given-names>S. A.</given-names></name>; <name><surname>Eichenberger</surname><given-names>E. M.</given-names></name>; <name><surname>Shah</surname><given-names>P. P.</given-names></name>; <name><surname>Carugati</surname><given-names>M.</given-names></name>; <name><surname>Holland</surname><given-names>T. L.</given-names></name>; <name><surname>Fowler</surname><given-names>V. G.</given-names></name><article-title>Methicillin-resistant
Staphylococcus aureus: an overview of basic and clinical research</article-title>. <source>Nat. Rev. Microbiol.</source><year>2019</year>, <volume>17</volume>, <fpage>203</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-018-0147-4</pub-id>.<pub-id pub-id-type="pmid">30737488</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Jariyasethpong</surname><given-names>T.</given-names></name>; <name><surname>Tribuddharat</surname><given-names>C.</given-names></name>; <name><surname>Dejsirilert</surname><given-names>S.</given-names></name>; <name><surname>Kerdsin</surname><given-names>A.</given-names></name>; <name><surname>Tishyadhigama</surname><given-names>P.</given-names></name>; <name><surname>Rahule</surname><given-names>S.</given-names></name>; <name><surname>Sawanpanyalert</surname><given-names>P.</given-names></name>; <name><surname>Yosapol</surname><given-names>P.</given-names></name>; <name><surname>Aswapokee</surname><given-names>N.</given-names></name><article-title>MRSA carriage
in a tertiary governmental hospital in Thailand: emphasis on prevalence
and molecular epidemiology</article-title>. <source>Eur. J. Clin. Microbiol.
Infect. Dis.</source><year>2010</year>, <volume>29</volume>, <fpage>977</fpage>–<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1007/s10096-010-0954-7</pub-id>.<pub-id pub-id-type="pmid">20509037</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><article-title>National Nosocomial Infections Surveillance (NNIS)
system report, data summary from January 1992 through June 2004, issued
October 2004</article-title>. <source>Am. J. Infect. Control</source><year>2004</year>, <volume>32</volume>, <fpage>470</fpage>–<lpage>485</lpage>.<pub-id pub-id-type="pmid">15573054</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Mojsoska</surname><given-names>B.</given-names></name>; <name><surname>Zuckermann</surname><given-names>R. N.</given-names></name>; <name><surname>Jenssen</surname><given-names>H.</given-names></name><article-title>Structure-activity relationship study
of novel peptoids that mimic the structure of antimicrobial peptides</article-title>. <source>Antimicrob. Agents Chemother.</source><year>2015</year>, <volume>59</volume>, <fpage>4112</fpage>–<lpage>4120</lpage>. <pub-id pub-id-type="doi">10.1128/aac.00237-15</pub-id>.<pub-id pub-id-type="pmid">25941221</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Huang</surname><given-names>Y.</given-names></name>; <name><surname>Huang</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name><article-title>Alpha-helical cationic antimicrobial
peptides: relationships of structure and function</article-title>. <source>Protein Cell</source><year>2010</year>, <volume>1</volume>, <fpage>143</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1007/s13238-010-0004-3</pub-id>.<pub-id pub-id-type="pmid">21203984</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Qiu</surname><given-names>X.-Q.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Lu</surname><given-names>X.-F.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>S.-F.</given-names></name>; <name><surname>Cheng</surname><given-names>G.</given-names></name>; <name><surname>Wan</surname><given-names>L.</given-names></name>; <name><surname>Yang</surname><given-names>L.</given-names></name>; <name><surname>Zuo</surname><given-names>J.-Y.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.-Q.</given-names></name>; <name><surname>Wang</surname><given-names>H.-Y.</given-names></name>; <name><surname>Cheng</surname><given-names>X.</given-names></name>; <name><surname>Zhang</surname><given-names>S.-H.</given-names></name>; <name><surname>Ou</surname><given-names>Z.-R.</given-names></name>; <name><surname>Zhong</surname><given-names>Z.-C.</given-names></name>; <name><surname>Cheng</surname><given-names>J.-Q.</given-names></name>; <name><surname>Li</surname><given-names>Y.-P.</given-names></name>; <name><surname>Wu</surname><given-names>G. Y.</given-names></name><article-title>An engineered multidomain
bactericidal peptide as a model for targeted
antibiotics against specific bacteria</article-title>. <source>Nat.
Biotechnol.</source><year>2003</year>, <volume>21</volume>, <fpage>1480</fpage>–<lpage>1485</lpage>. <pub-id pub-id-type="doi">10.1038/nbt913</pub-id>.<pub-id pub-id-type="pmid">14625561</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Shi</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Zhou</surname><given-names>M.</given-names></name>; <name><surname>Xi</surname><given-names>X.</given-names></name>; <name><surname>Cheng</surname><given-names>J.</given-names></name>; <name><surname>Ma</surname><given-names>C.</given-names></name>; <name><surname>Chen</surname><given-names>T.</given-names></name>; <name><surname>Shaw</surname><given-names>C.</given-names></name><article-title>A novel amphibian
antimicrobial peptide, phylloseptin-PV1, exhibits effective anti-staphylococcal
activity without inducing either hepatic or renal toxicity in mice</article-title>. <source>Front. Microbiol.</source><year>2020</year>, <volume>11</volume>, <fpage>565158</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.565158</pub-id>.<pub-id pub-id-type="pmid">33193152</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Wang</surname><given-names>G.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name><article-title>APD3: the
antimicrobial peptide database as a tool
for research and education</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>, <volume>44</volume>, <fpage>D1087</fpage>–<lpage>D1093</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1278</pub-id>.<pub-id pub-id-type="pmid">26602694</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Pang</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name>; <name><surname>Jhong</surname><given-names>J.-H.</given-names></name>; <name><surname>Lee</surname><given-names>T.-Y.</given-names></name><article-title>Identifying
anti-coronavirus
peptides by incorporating different negative datasets and imbalanced
learning strategies</article-title>. <source>Briefings Bioinf.</source><year>2021</year>, <volume>22</volume>, <fpage>1085</fpage>–<lpage>1095</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbaa423</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Huang</surname><given-names>H.-L.</given-names></name>; <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Kao</surname><given-names>T.-F.</given-names></name>; <name><surname>Lee</surname><given-names>H.-C.</given-names></name>; <name><surname>Chang</surname><given-names>F.-L.</given-names></name>; <name><surname>Huang</surname><given-names>W.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-J.</given-names></name>; <name><surname>Shu</surname><given-names>L.-S.</given-names></name>; <name><surname>Chen</surname><given-names>W.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-Y.</given-names></name><article-title>Prediction and analysis of protein
solubility using a novel scoring
card method with dipeptide composition</article-title>. <source>BMC
Bioinf.</source><year>2012</year>, <volume>13</volume>, <fpage>S3</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-13-s17-s3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Chiangjong</surname><given-names>W.</given-names></name>; <name><surname>Lee</surname><given-names>V. S.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Hasan</surname><given-names>M. M.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>Improved prediction
and characterization
of anticancer activities of peptides using a novel flexible scoring
card method</article-title>. <source>Sci. Rep.</source><year>2021</year>, <volume>11</volume>, <fpage>3017</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-82513-9</pub-id>.<pub-id pub-id-type="pmid">33542286</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>; <name><surname>Lee</surname><given-names>H.-C.</given-names></name>; <name><surname>Chaijaruwanich</surname><given-names>J.</given-names></name>; <name><surname>Huang</surname><given-names>H.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-Y.</given-names></name><article-title>SCMCRYS: predicting protein crystallization
using an ensemble scoring card method with estimating propensity scores
of P-collocated amino acid pairs</article-title>. <source>PLoS One</source><year>2013</year>, <volume>8</volume>, <elocation-id>e72368</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0072368</pub-id>.<pub-id pub-id-type="pmid">24019868</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Vasylenko</surname><given-names>T.</given-names></name>; <name><surname>Liou</surname><given-names>Y.-F.</given-names></name>; <name><surname>Chiou</surname><given-names>P.-C.</given-names></name>; <name><surname>Chu</surname><given-names>H.-W.</given-names></name>; <name><surname>Lai</surname><given-names>Y.-S.</given-names></name>; <name><surname>Chou</surname><given-names>Y.-L.</given-names></name>; <name><surname>Huang</surname><given-names>H.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-Y.</given-names></name><article-title>SCMBYK: prediction
and characterization of bacterial tyrosine-kinases based on propensity
scores of dipeptides</article-title>. <source>BMC Bioinf.</source><year>2016</year>, <volume>17</volume>, <fpage>514</fpage><pub-id pub-id-type="doi">10.1186/s12859-016-1371-4</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Liou</surname><given-names>Y.-F.</given-names></name>; <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Srinivasulu</surname><given-names>Y. S.</given-names></name>; <name><surname>Vasylenko</surname><given-names>T.</given-names></name>; <name><surname>Lai</surname><given-names>S.-C.</given-names></name>; <name><surname>Lee</surname><given-names>H.-C.</given-names></name>; <name><surname>Chen</surname><given-names>Y.-H.</given-names></name>; <name><surname>Huang</surname><given-names>H.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-Y.</given-names></name><article-title>SCMHBP: prediction and analysis of
heme binding proteins using propensity
scores of dipeptides</article-title>. <source>BMC Bioinf.</source><year>2014</year>, <volume>15</volume>, <fpage>S4</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-15-s16-s4</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Vasylenko</surname><given-names>T.</given-names></name>; <name><surname>Liou</surname><given-names>Y.-F.</given-names></name>; <name><surname>Chen</surname><given-names>H.-A.</given-names></name>; <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Huang</surname><given-names>H.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-Y.</given-names></name><article-title>SCMPSP: Prediction and characterization
of photosynthetic proteins based on a scoring card method</article-title>. <source>BMC Bioinf.</source><year>2015</year>, <volume>16</volume>, <fpage>S8</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-16-s1-s8</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Xie</surname><given-names>R.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Dai</surname><given-names>W.</given-names></name>; <name><surname>Leier</surname><given-names>A.</given-names></name>; <name><surname>Marquez-Lago</surname><given-names>T. T.</given-names></name>; <name><surname>Akutsu</surname><given-names>T.</given-names></name>; <name><surname>Lithgow</surname><given-names>T.</given-names></name>; <name><surname>Song</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name><article-title>DeepVF: a
deep learning-based hybrid framework for identifying virulence factors
using the stacking strategy</article-title>. <source>Briefings Bioinf.</source><year>2021</year>, <volume>22</volume>, <fpage>bbaa125</fpage><pub-id pub-id-type="doi">10.1093/bib/bbaa125</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Chotpatiwetchkul</surname><given-names>W.</given-names></name>; <name><surname>Lee</surname><given-names>V. S.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>A novel sequence-based predictor for identifying and
characterizing thermophilic proteins using estimated propensity scores
of dipeptides</article-title>. <source>Sci. Rep.</source><year>2021</year>, <volume>11</volume>, <fpage>23782</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-03293-w</pub-id>.<pub-id pub-id-type="pmid">34893688</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Chen</surname><given-names>Z.</given-names></name>; <name><surname>Zhao</surname><given-names>P.</given-names></name>; <name><surname>Li</surname><given-names>F.</given-names></name>; <name><surname>Leier</surname><given-names>A.</given-names></name>; <name><surname>Marquez-Lago</surname><given-names>T. T.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Webb</surname><given-names>G. I.</given-names></name>; <name><surname>Smith</surname><given-names>A. I.</given-names></name>; <name><surname>Daly</surname><given-names>R. J.</given-names></name>; <name><surname>Chou</surname><given-names>K.-C.</given-names></name>; <name><surname>Song</surname><given-names>J.</given-names></name><article-title>iFeature: a python package and web
server for features extraction and selection from protein and peptide
sequences</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>2499</fpage>–<lpage>2502</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty140</pub-id>.<pub-id pub-id-type="pmid">29528364</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Pedregosa</surname><given-names>F.</given-names></name>; <name><surname>Varoquaux</surname><given-names>G.</given-names></name>; <name><surname>Gramfort</surname><given-names>A.</given-names></name>; <name><surname>Michel</surname><given-names>V.</given-names></name>; <name><surname>Thirion</surname><given-names>B.</given-names></name>; <name><surname>Grisel</surname><given-names>O.</given-names></name>; <name><surname>Blondel</surname><given-names>M.</given-names></name>; <name><surname>Prettenhofer</surname><given-names>P.</given-names></name>; <name><surname>Weiss</surname><given-names>R.</given-names></name>; <name><surname>Dubourg</surname><given-names>V.</given-names></name><article-title>Scikit-learn: Machine learning in
Python</article-title>. <source>J. Mach. Learn. Res.</source><year>2011</year>, <volume>12</volume>, <fpage>2825</fpage>–<lpage>2830</lpage>.</mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Su</surname><given-names>R.</given-names></name>; <name><surname>Hu</surname><given-names>J.</given-names></name>; <name><surname>Zou</surname><given-names>Q.</given-names></name>; <name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Wei</surname><given-names>L.</given-names></name><article-title>Empirical comparison
and analysis of web-based cell-penetrating peptide prediction tools</article-title>. <source>Briefings Bioinf.</source><year>2020</year>, <volume>21</volume>, <fpage>408</fpage>–<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bby124</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Basith</surname><given-names>S.</given-names></name>; <name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Hwan Shin</surname><given-names>T.</given-names></name>; <name><surname>Lee</surname><given-names>G.</given-names></name><article-title>Machine intelligence
in peptide therapeutics: A next-generation tool for rapid disease
screening</article-title>. <source>Med. Res. Rev.</source><year>2020</year>, <volume>40</volume>, <fpage>1276</fpage>–<lpage>1314</lpage>. <pub-id pub-id-type="doi">10.1002/med.21658</pub-id>.<pub-id pub-id-type="pmid">31922268</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="book" id="cit25"><person-group person-group-type="allauthors"><name><surname>Shoombuatong</surname><given-names>W.</given-names></name>; <name><surname>Prathipati</surname><given-names>P.</given-names></name>; <name><surname>Owasirikul</surname><given-names>W.</given-names></name>; <name><surname>Worachartcheewan</surname><given-names>A.</given-names></name>; <name><surname>Simeon</surname><given-names>S.</given-names></name>; <name><surname>Anuwongcharoen</surname><given-names>N.</given-names></name>; <name><surname>Wikberg</surname><given-names>J. E.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name></person-group>, <article-title>Towards
the revival of interpretable QSAR models</article-title>. <source>Advances in QSAR Modeling</source>; <publisher-name>Springer</publisher-name>, <year>2017</year>; pp <fpage>3</fpage>–<lpage>55</lpage>.</mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Hasan</surname><given-names>M. M.</given-names></name>; <name><surname>Schaduangrat</surname><given-names>N.</given-names></name>; <name><surname>Basith</surname><given-names>S.</given-names></name>; <name><surname>Lee</surname><given-names>G.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>; <name><surname>Manavalan</surname><given-names>B.</given-names></name><article-title>HLPpred-Fuse: improved and robust prediction of hemolytic
peptide and its activity by fusing multiple feature representation</article-title>. <source>Bioinformatics</source><year>2020</year>, <volume>36</volume>, <fpage>3350</fpage>–<lpage>3356</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa160</pub-id>.<pub-id pub-id-type="pmid">32145017</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Kanthawong</surname><given-names>S.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Hasan</surname><given-names>M. M.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>iAMY-SCM:
Improved prediction and analysis of amyloid proteins using a scoring
card method with propensity scores of dipeptides</article-title>. <source>Genomics</source><year>2021</year>, <volume>113</volume>, <fpage>689</fpage><pub-id pub-id-type="doi">10.1016/j.ygeno.2020.09.065</pub-id>.<pub-id pub-id-type="pmid">33017626</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Azadpour</surname><given-names>M.</given-names></name>; <name><surname>McKay</surname><given-names>C. M.</given-names></name>; <name><surname>Smith</surname><given-names>R. L.</given-names></name><article-title>Estimating
confidence intervals for
information transfer analysis of confusion matrices</article-title>. <source>J. Acoust. Soc. Am.</source><year>2014</year>, <volume>135</volume>, <fpage>EL140</fpage>–<lpage>EL146</lpage>. <pub-id pub-id-type="doi">10.1121/1.4865840</pub-id>.<pub-id pub-id-type="pmid">24606307</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Zhang</surname><given-names>D.</given-names></name>; <name><surname>Xu</surname><given-names>Z.-C.</given-names></name>; <name><surname>Su</surname><given-names>W.</given-names></name>; <name><surname>Yang</surname><given-names>Y.-H.</given-names></name>; <name><surname>Lv</surname><given-names>H.</given-names></name>; <name><surname>Yang</surname><given-names>H.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name><article-title>iCarPS: a
computational tool for
identifying protein carbonylation sites by novel encoded features</article-title>. <source>Bioinformatics</source><year>2021</year>, <volume>37</volume>, <fpage>171</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa702</pub-id>.<pub-id pub-id-type="pmid">32766811</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Chiangjong</surname><given-names>W.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Hasan</surname><given-names>M. M.</given-names></name>; <name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>StackIL6: a stacking ensemble model for improving the
prediction of IL-6 inducing peptides</article-title>. <source>Briefings
Bioinf.</source><year>2021</year>, <volume>22</volume>, <fpage>bbab172</fpage><pub-id pub-id-type="doi">10.1093/bib/bbab172</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Gong</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>G.</given-names></name><article-title>Detection
of transcription factors binding to methylated DNA by deep recurrent
neural network</article-title>. <source>Briefings Bioinf.</source><year>2022</year>, <volume>23</volume>, <fpage>bbab533</fpage><pub-id pub-id-type="doi">10.1093/bib/bbab533</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Zulfiqar</surname><given-names>H.</given-names></name>; <name><surname>Yuan</surname><given-names>S.-S.</given-names></name>; <name><surname>Huang</surname><given-names>Q.-L.</given-names></name>; <name><surname>Sun</surname><given-names>Z.-J.</given-names></name>; <name><surname>Dao</surname><given-names>F.-Y.</given-names></name>; <name><surname>Yu</surname><given-names>X.-L.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name><article-title>Identification of cyclin protein
using gradient boost decision tree algorithm</article-title>. <source>Comput. Struct. Biotechnol. J.</source><year>2021</year>, <volume>19</volume>, <fpage>4123</fpage>–<lpage>4131</lpage>. <pub-id pub-id-type="doi">10.1016/j.csbj.2021.07.013</pub-id>.<pub-id pub-id-type="pmid">34527186</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Nagarajan</surname><given-names>D.</given-names></name>; <name><surname>Roy</surname><given-names>N.</given-names></name>; <name><surname>Kulkarni</surname><given-names>O.</given-names></name>; <name><surname>Nanajkar</surname><given-names>N.</given-names></name>; <name><surname>Datey</surname><given-names>A.</given-names></name>; <name><surname>Ravichandran</surname><given-names>S.</given-names></name>; <name><surname>Thakur</surname><given-names>C.</given-names></name>; <name><surname>T</surname><given-names>I. V.</given-names></name>; <name><surname>Aprameya</surname><given-names>S. P.</given-names></name>; <name><surname>Sarma</surname><given-names>D.</given-names></name>; <name><surname>Chakravortty</surname><given-names>D.</given-names></name>; <name><surname>Chandra</surname><given-names>N.</given-names></name><article-title>Ω76: A designed antimicrobial
peptide to combat carbapenem-and tigecycline-resistant Acinetobacter
baumannii</article-title>. <source>Sci. Adv.</source><year>2019</year>, <volume>5</volume>, <elocation-id>eaax1946</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aax1946</pub-id>.<pub-id pub-id-type="pmid">31355341</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Abbassi</surname><given-names>F.</given-names></name>; <name><surname>Raja</surname><given-names>Z.</given-names></name>; <name><surname>Oury</surname><given-names>B.</given-names></name>; <name><surname>Gazanion</surname><given-names>E.</given-names></name>; <name><surname>Piesse</surname><given-names>C.</given-names></name>; <name><surname>Sereno</surname><given-names>D.</given-names></name>; <name><surname>Nicolas</surname><given-names>P.</given-names></name>; <name><surname>Foulon</surname><given-names>T.</given-names></name>; <name><surname>Ladram</surname><given-names>A.</given-names></name><article-title>Antibacterial
and leishmanicidal activities of temporin-SHd, a 17-residue long membrane-damaging
peptide</article-title>. <source>Biochimie</source><year>2013</year>, <volume>95</volume>, <fpage>388</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1016/j.biochi.2012.10.015</pub-id>.<pub-id pub-id-type="pmid">23116712</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Peel</surname><given-names>E.</given-names></name>; <name><surname>Cheng</surname><given-names>Y.</given-names></name>; <name><surname>Djordjevic</surname><given-names>J.</given-names></name>; <name><surname>Fox</surname><given-names>S.</given-names></name>; <name><surname>Sorrell</surname><given-names>T.</given-names></name>; <name><surname>Belov</surname><given-names>K.</given-names></name><article-title>Cathelicidins in the Tasmanian devil
(Sarcophilus harrisii)</article-title>. <source>Sci. Rep.</source><year>2016</year>, <volume>6</volume>, <fpage>35019</fpage><pub-id pub-id-type="doi">10.1038/srep35019</pub-id>.<pub-id pub-id-type="pmid">27725697</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Zai</surname><given-names>Y.</given-names></name>; <name><surname>Xi</surname><given-names>X.</given-names></name>; <name><surname>Ye</surname><given-names>Z.</given-names></name>; <name><surname>Ma</surname><given-names>C.</given-names></name>; <name><surname>Zhou</surname><given-names>M.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Siu</surname><given-names>S. W.</given-names></name>; <name><surname>Chen</surname><given-names>T.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Kwok</surname><given-names>H. F.</given-names></name><article-title>Aggregation
and its influence on the bioactivities of a novel antimicrobial peptide,
temporin-PF, and its analogues</article-title>. <source>Int. J. Mol.
Sci.</source><year>2021</year>, <volume>22</volume>, <fpage>4509</fpage><pub-id pub-id-type="doi">10.3390/ijms22094509</pub-id>.<pub-id pub-id-type="pmid">33925935</pub-id></mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>Mishra</surname><given-names>B.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Lushnikova</surname><given-names>T.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Golla</surname><given-names>R. M.</given-names></name>; <name><surname>Narayana</surname><given-names>J. L.</given-names></name>; <name><surname>Wang</surname><given-names>C.</given-names></name>; <name><surname>McGuire</surname><given-names>T. R.</given-names></name>; <name><surname>Wang</surname><given-names>G.</given-names></name><article-title>Antibacterial,
antifungal, anticancer activities and structural bioinformatics analysis
of six naturally occurring temporins</article-title>. <source>Peptides</source><year>2018</year>, <volume>106</volume>, <fpage>9</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2018.05.011</pub-id>.<pub-id pub-id-type="pmid">29842923</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Conlon</surname><given-names>J. M.</given-names></name>; <name><surname>Abraham</surname><given-names>B.</given-names></name>; <name><surname>Sonnevend</surname><given-names>A.</given-names></name>; <name><surname>Jouenne</surname><given-names>T.</given-names></name>; <name><surname>Cosette</surname><given-names>P.</given-names></name>; <name><surname>Leprince</surname><given-names>J.</given-names></name>; <name><surname>Vaudry</surname><given-names>H.</given-names></name>; <name><surname>Bevier</surname><given-names>C. R.</given-names></name><article-title>Purification and
characterization of antimicrobial peptides from the skin secretions
of the carpenter frog Rana virgatipes (Ranidae, Aquarana)</article-title>. <source>Regul. Pept.</source><year>2005</year>, <volume>131</volume>, <fpage>38</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.regpep.2005.06.003</pub-id>.<pub-id pub-id-type="pmid">15996769</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>de
Barros</surname><given-names>E.</given-names></name>; <name><surname>Gonçalves</surname><given-names>R. M.</given-names></name>; <name><surname>Cardoso</surname><given-names>M. H.</given-names></name>; <name><surname>Santos</surname><given-names>N. C.</given-names></name>; <name><surname>Franco</surname><given-names>O. L.</given-names></name>; <name><surname>Cândido</surname><given-names>E. S.</given-names></name><article-title>Snake venom cathelicidins as natural
antimicrobial peptides</article-title>. <source>Front. Pharmacol.</source><year>2019</year>, <volume>10</volume>, <fpage>1415</fpage><pub-id pub-id-type="doi">10.3389/fphar.2019.01415</pub-id>.<pub-id pub-id-type="pmid">31849667</pub-id></mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><name><surname>Gopal</surname><given-names>R.</given-names></name>; <name><surname>Lee</surname><given-names>J. H.</given-names></name>; <name><surname>Kim</surname><given-names>Y. G.</given-names></name>; <name><surname>Kim</surname><given-names>M.-S.</given-names></name>; <name><surname>Seo</surname><given-names>C. H.</given-names></name>; <name><surname>Park</surname><given-names>Y.</given-names></name><article-title>Anti-microbial, anti-biofilm activities
and cell selectivity of the
NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus</article-title>. <source>Mar. Drugs</source><year>2013</year>, <volume>11</volume>, <fpage>1836</fpage>–<lpage>1852</lpage>. <pub-id pub-id-type="doi">10.3390/md11061836</pub-id>.<pub-id pub-id-type="pmid">23760014</pub-id></mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Conlon</surname><given-names>J. M.</given-names></name>; <name><surname>Mechkarska</surname><given-names>M.</given-names></name>; <name><surname>Prajeep</surname><given-names>M.</given-names></name>; <name><surname>Sonnevend</surname><given-names>A.</given-names></name>; <name><surname>Coquet</surname><given-names>L.</given-names></name>; <name><surname>Leprince</surname><given-names>J.</given-names></name>; <name><surname>Jouenne</surname><given-names>T.</given-names></name>; <name><surname>Vaudry</surname><given-names>H.</given-names></name>; <name><surname>King</surname><given-names>J. D.</given-names></name><article-title>Host-defense peptides
in skin secretions of the tetraploid
frog Silurana epitropicalis with potent activity against methicillin-resistant
Staphylococcus aureus (MRSA)</article-title>. <source>Peptides</source><year>2012</year>, <volume>37</volume>, <fpage>113</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2012.07.005</pub-id>.<pub-id pub-id-type="pmid">22800690</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Abraham</surname><given-names>P.</given-names></name>; <name><surname>George</surname><given-names>S.</given-names></name>; <name><surname>Kumar</surname><given-names>K. S.</given-names></name><article-title>Novel antibacterial
peptides from
the skin secretion of the Indian bicoloured frog <italic>Clinotarsus
curtipes</italic></article-title>. <source>Biochimie</source><year>2014</year>, <volume>97</volume>, <fpage>144</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.biochi.2013.10.005</pub-id>.<pub-id pub-id-type="pmid">24161537</pub-id></mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Mishra</surname><given-names>B.</given-names></name>; <name><surname>Wang</surname><given-names>G.</given-names></name><article-title>Ab initio design of potent anti-MRSA
peptides based on database filtering
technology</article-title>. <source>J. Am. Chem. Soc.</source><year>2012</year>, <volume>134</volume>, <fpage>12426</fpage>–<lpage>12429</lpage>. <pub-id pub-id-type="doi">10.1021/ja305644e</pub-id>.<pub-id pub-id-type="pmid">22803960</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Patrzykat</surname><given-names>A.</given-names></name>; <name><surname>Gallant</surname><given-names>J. W.</given-names></name>; <name><surname>Seo</surname><given-names>J.-K.</given-names></name>; <name><surname>Pytyck</surname><given-names>J.</given-names></name>; <name><surname>Douglas</surname><given-names>S. E.</given-names></name><article-title>Novel antimicrobial
peptides derived from flatfish genes</article-title>. <source>Antimicrob.
Agents Chemother.</source><year>2003</year>, <volume>47</volume>, <fpage>2464</fpage>–<lpage>2470</lpage>. <pub-id pub-id-type="doi">10.1128/aac.47.8.2464-2470.2003</pub-id>.<pub-id pub-id-type="pmid">12878506</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Clark</surname><given-names>D. P.</given-names></name>; <name><surname>Durell</surname><given-names>S.</given-names></name>; <name><surname>Maloy</surname><given-names>W. L.</given-names></name>; <name><surname>Zasloff</surname><given-names>M.</given-names></name><article-title>Ranalexin. A novel
antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally
related to the bacterial antibiotic, polymyxin</article-title>. <source>J. Biol. Chem.</source><year>1994</year>, <volume>269</volume>, <fpage>10849</fpage>–<lpage>10855</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(17)34136-4</pub-id>.<pub-id pub-id-type="pmid">8144672</pub-id></mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Chen</surname><given-names>Q.</given-names></name>; <name><surname>Cheng</surname><given-names>P.</given-names></name>; <name><surname>Ma</surname><given-names>C.</given-names></name>; <name><surname>Xi</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Zhou</surname><given-names>M.</given-names></name>; <name><surname>Bian</surname><given-names>H.</given-names></name>; <name><surname>Chen</surname><given-names>T.</given-names></name><article-title>Evaluating
the bioactivity
of a novel broad-spectrum antimicrobial peptide brevinin-1gha from
the frog skin secretion of <italic>hylarana guentheri</italic> and
its analogues</article-title>. <source>Toxins</source><year>2018</year>, <volume>10</volume>, <fpage>413</fpage><pub-id pub-id-type="doi">10.3390/toxins10100413</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Dong</surname><given-names>Z.</given-names></name>; <name><surname>Luo</surname><given-names>W.</given-names></name>; <name><surname>Zhong</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>M.</given-names></name>; <name><surname>Song</surname><given-names>Y.</given-names></name>; <name><surname>Deng</surname><given-names>S.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name><article-title>Molecular cloning and characterization of antimicrobial peptides
from skin of <italic>Hylarana guentheri</italic></article-title>. <source>Acta Biochim. Biophys. Sin.</source><year>2017</year>, <volume>49</volume>, <fpage>450</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1093/abbs/gmx023</pub-id>.<pub-id pub-id-type="pmid">28338958</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Jin-Jiang</surname><given-names>H.</given-names></name>; <name><surname>Jin-Chun</surname><given-names>L.</given-names></name>; <name><surname>Min</surname><given-names>L.</given-names></name>; <name><surname>Qing-Shan</surname><given-names>H.</given-names></name>; <name><surname>Guo-Dong</surname><given-names>L.</given-names></name><article-title>The design and construction of K11:
a novel α-helical
antimicrobial peptide</article-title>. <source>Int. J. Microbiol.</source><year>2012</year>, <volume>2012</volume>, <fpage>764834</fpage><pub-id pub-id-type="doi">10.1155/2012/764834</pub-id>.<pub-id pub-id-type="pmid">22518150</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Mangoni</surname><given-names>M.</given-names></name><article-title>Temporins,
anti-infective peptides with expanding properties</article-title>. <source>Cell. Mol. Life Sci.</source><year>2006</year>, <volume>63</volume>, <fpage>1060</fpage>–<lpage>1069</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-005-5536-y</pub-id>.<pub-id pub-id-type="pmid">16572270</pub-id></mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="journal" id="cit50"><name><surname>Xie</surname><given-names>Z.</given-names></name>; <name><surname>Wei</surname><given-names>H.</given-names></name>; <name><surname>Meng</surname><given-names>J.</given-names></name>; <name><surname>Cheng</surname><given-names>T.</given-names></name>; <name><surname>Song</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>M.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name><article-title>The analogs of temporin-GHa exhibit a broader spectrum of antimicrobial
activity and a stronger antibiofilm potential against Staphylococcus
aureus</article-title>. <source>Molecules</source><year>2019</year>, <volume>24</volume>, <fpage>4173</fpage><pub-id pub-id-type="doi">10.3390/molecules24224173</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Mishra</surname><given-names>B.</given-names></name>; <name><surname>Wang</surname><given-names>G.</given-names></name><article-title>The importance of amino acid composition in natural AMPs: an evolutional,
structural, and functional perspective</article-title>. <source>Front.
Immunol.</source><year>2012</year>, <volume>3</volume>, <fpage>221</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2012.00221</pub-id>.<pub-id pub-id-type="pmid">23060873</pub-id></mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>Zouhir</surname><given-names>A.</given-names></name>; <name><surname>Jridi</surname><given-names>T.</given-names></name>; <name><surname>Nefzi</surname><given-names>A.</given-names></name>; <name><surname>Ben Hamida</surname><given-names>J.</given-names></name>; <name><surname>Sebei</surname><given-names>K.</given-names></name><article-title>Inhibition of methicillin-resistant Staphylococcus aureus (MRSA)
by antimicrobial peptides (AMPs) and plant essential oils</article-title>. <source>Pharm. Biol.</source><year>2016</year>, <volume>54</volume>, <fpage>3136</fpage>–<lpage>3150</lpage>. <pub-id pub-id-type="doi">10.1080/13880209.2016.1190763</pub-id>.<pub-id pub-id-type="pmid">27246787</pub-id></mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Shang</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Song</surname><given-names>C.</given-names></name>; <name><surname>Nina</surname><given-names>Z.</given-names></name>; <name><surname>Li</surname><given-names>Q.</given-names></name>; <name><surname>Chou</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name>; <name><surname>Shan</surname><given-names>A.</given-names></name><article-title>Hybrid antimicrobial peptide targeting
Staphylococcus aureus and displaying anti-infective activity in a
murine model</article-title>. <source>Front. Microbiol.</source><year>2020</year>, <volume>11</volume>, <fpage>1767</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.01767</pub-id>.<pub-id pub-id-type="pmid">33042031</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Zarena</surname><given-names>D.</given-names></name>; <name><surname>Mishra</surname><given-names>B.</given-names></name>; <name><surname>Lushnikova</surname><given-names>T.</given-names></name>; <name><surname>Wang</surname><given-names>F.</given-names></name>; <name><surname>Wang</surname><given-names>G.</given-names></name><article-title>The π
configuration of the WWW motif of a short Trp-rich peptide is critical
for targeting bacterial membranes, disrupting preformed biofilms,
and killing methicillin-resistant Staphylococcus aureus</article-title>. <source>Biochemistry</source><year>2017</year>, <volume>56</volume>, <fpage>4039</fpage>–<lpage>4043</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biochem.7b00456</pub-id>.<pub-id pub-id-type="pmid">28731688</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Sharma</surname><given-names>A.</given-names></name>; <name><surname>Kapoor</surname><given-names>P.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Chauhan</surname><given-names>J. S.</given-names></name>; <name><surname>Tyagi</surname><given-names>A.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P.</given-names></name><article-title>Computational
approach for designing tumor homing peptides</article-title>. <source>Sci. Rep.</source><year>2013</year>, <volume>3</volume>, <fpage>1607</fpage><pub-id pub-id-type="doi">10.1038/srep01607</pub-id>.<pub-id pub-id-type="pmid">23558316</pub-id></mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Nagpal</surname><given-names>G.</given-names></name>; <name><surname>Usmani</surname><given-names>S. S.</given-names></name>; <name><surname>Dhanda</surname><given-names>S. K.</given-names></name>; <name><surname>Kaur</surname><given-names>H.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P.</given-names></name><article-title>Computer-aided designing of immunosuppressive
peptides based on IL-10 inducing potential</article-title>. <source>Sci. Rep.</source><year>2017</year>, <volume>7</volume>, <fpage>42851</fpage><pub-id pub-id-type="doi">10.1038/srep42851</pub-id>.<pub-id pub-id-type="pmid">28211521</pub-id></mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Chauhan</surname><given-names>J. S.</given-names></name>; <name><surname>Nagpal</surname><given-names>G.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P.</given-names></name><article-title>An in silico platform for predicting,
screening and designing of antihypertensive peptides</article-title>. <source>Sci. Rep.</source><year>2015</year>, <volume>5</volume>, <fpage>12512</fpage><pub-id pub-id-type="doi">10.1038/srep12512</pub-id>.<pub-id pub-id-type="pmid">26213115</pub-id></mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Tuknait</surname><given-names>A.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Mathur</surname><given-names>D.</given-names></name>; <name><surname>Anand</surname><given-names>P.</given-names></name>; <name><surname>Varshney</surname><given-names>G. C.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P.</given-names></name><article-title>A web server
and mobile app for computing hemolytic potency of peptides</article-title>. <source>Sci. Rep.</source><year>2016</year>, <volume>6</volume>, <fpage>22843</fpage><pub-id pub-id-type="doi">10.1038/srep22843</pub-id>.<pub-id pub-id-type="pmid">26953092</pub-id></mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Klein</surname><given-names>P.</given-names></name>; <name><surname>Kanehisa</surname><given-names>M.</given-names></name>; <name><surname>DeLisi</surname><given-names>C.</given-names></name><article-title>Prediction
of protein function from
sequence properties: Discriminant analysis of a data base</article-title>. <source>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</source><year>1984</year>, <volume>787</volume>, <fpage>221</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/0167-4838(84)90312-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Wang</surname><given-names>Z.</given-names></name>; <name><surname>Wang</surname><given-names>G.</given-names></name><article-title>APD: the antimicrobial
peptide database</article-title>. <source>Nucleic
Acids Res.</source><year>2004</year>, <volume>32</volume>, <fpage>D590</fpage>–<lpage>D592</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh025</pub-id>.<pub-id pub-id-type="pmid">14681488</pub-id></mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Zimmerman</surname><given-names>J.</given-names></name>; <name><surname>Eliezer</surname><given-names>N.</given-names></name>; <name><surname>Simha</surname><given-names>R.</given-names></name><article-title>The characterization
of amino acid
sequences in proteins by statistical methods</article-title>. <source>J. Theor. Biol.</source><year>1968</year>, <volume>21</volume>, <fpage>170</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/0022-5193(68)90069-6</pub-id>.<pub-id pub-id-type="pmid">5700434</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Wimley</surname><given-names>W. C.</given-names></name>; <name><surname>White</surname><given-names>S. H.</given-names></name><article-title>Experimentally determined
hydrophobicity scale for
proteins at membrane interfaces</article-title>. <source>Nat. Struct.
Biol.</source><year>1996</year>, <volume>3</volume>, <fpage>842</fpage>–<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1038/nsb1096-842</pub-id>.<pub-id pub-id-type="pmid">8836100</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
